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Summary   
Although the molecular mechanisms by which haemoglobinopathic erythrocytes protect their 
carriers against life-threatening complications of severe malaria have yet to be elucidated, one 
of the contributing factors is believed to be reduced cytoadhesion in the microvasculatures of 
vital organs. Previous studies have described perturbations in host actin remodelling, reduced 
surface levels of PfEMP1 adhesin, abnormal knob sizes and distributions as well as malformed 
Maurer’s clefts in infected haemoglobinopathic erythrocytes, relative to those seen in infected 
HbAA erythrocytes. 
We attempted to establish super-resolution imaging with direct stochastic optical reconstruction 
microscopy (dSTORM) as an intermediate throughput method of visualising host actin 
remodelling in infected erythrocytes. Unfortunately, individual F-actin and spectrin filaments 
could not be resolved and no significant differences in the actin and spectrin labelling of 
uninfected versus infected erythrocytes were distinguishable.  
We also further explored the kinetics of adhesion phenotype and protein transport in 
haemaglobinopathic erythrocytes. We found that infected HbAS erythrocytes exhibited slower 
temporal increase in number of adherent cells as well as a lower total number of adherent cell 
relative to infected HbAA erythrocytes. A delay in the establishment of new permeability 
pathway (NPP) was also observed in infected haemoglobinopathic erythrocytes. 
We tested the hypothesis that the inherent redox imbalance found in uninfected 
haemoglobinopathic erythrocytes is the beginning of a cascade of events which precipitates in 
the reduced cytoadhesive phonotype associated with protection against severe malaria. By 
exposing uninfected HbAA erythrocytes to transient oxidative stress, we were able to mimic 
various phenotypes associated with the protective traits, including reduced cytoadhesion and 
surface PfEMP1 levels, malformed and dispersed knobs, aberrant Maurer’s cleft morphologies 
and inability to remodel host actin cytoskeleton.   
Taken together, our findings describe a cascade of events which begins with the redox 
imbalance inherent to uninfected haemoglobinopathic erythrocytes. This oxidative milieu 
interferes with parasitic protein export, host actin remodelling and knobs and Maurer’s cleft 
formation, which leads to aberrant display of PfEMP1 on the cell surface and a reduced level 
of cytoadhesion. This helps to alleviate the life-threatening consequences of severe malaria.     
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Zusammenfassung  
Obwohl die molekularen Mechanismen durch die hämoglobinopathische Erythrozyten ihre 
Träger gegen lebensbedrohliche Komplikationen schwerer Malaria schützen noch nicht geklärt 
sind, wird als einer der beitragenden Faktoren eine verminderte Zytoadhäsion in der 
Mikrovaskulatur lebenswichtiger Organe vermutet. Frühere Studien haben Störungen der 
Wirts-Aktin Remodellierung, eine reduzierte Expression des Adhäsins PfEMP1 an der 
Oberfläche von Erythrozyten, eine abnormale Größe und Verteilung von Knobs sowie 
fehlgeformte Maurer-Spalten in infizierten hämoglobinopathischen Erythrozyten im Vergleich 
zu infizierten HbAA-Erythrozyten beschrieben.  
 
Wir haben versucht, eine hochauflösende Bildgebung mittels direkter stochastischer optischer 
Rekonstruktionsmikroskopie (dSTORM) als intermediärer Durchsatzmethode zur 
Visualisierung der Wirts-Aktin Remodellierung in infizierten Erythrozyten zu etablieren. 
Unglücklicherweise konnten einzelne F-Aktin- und Spektrinfilamente nicht aufgelöst werden, 
zudem wurden keine signifikanten Unterschiede in der Aktin- und Spektrinmarkierung von 
nicht-infizierten gegenüber infizierten Erythrozyten gefunden. 
Wir untersuchten auch die Kinetiken des Adhäsionsphänotyps und des Proteintransports in 
hämoglobinopathischen Erythrozyten. Wir konnten zeigen, dass infizierte HbAS-Erythrozyten 
einen langsameren zeitlichen Anstieg der Anzahl adhärenter Zellen sowie eine geringere 
Gesamtanzahl adhärenter Zellen im Vergleich zu infizierten HbAA-Erythrozyten aufwiesen. 
Des Weiteren konnte auch eine Verzögerung bei der Etablierung des neuen 
Permeabilitätsweges (NPP) in infizierten hämoglobinopathischen Erythrozyten beobachtet 
werden. 
Wir testeten die Hypothese, dass das in nicht infizierten hämoglobinopathischen Erythrozyten 
vorhandene inhärente Redox-Ungleichgewicht der Beginn einer Kaskade von Ereignissen ist, 
die schlußendlich zu dem reduzierten zytoadhäsiven Phänotyp führen, der mit dem Schutz vor 
schwerer Malaria assoziiert ist. Indem wir nicht infizierte HbAA-Erythrozyten transientem 
oxidativen Stress aussetzten, konnten wir verschiedene, mit den schützenden Eigenschaften 
assoziierte Phänotypen nachahmen, einschließlich verringerter Zytoadhäsion und 
Oberflächenexpression von PfEMP1, fehlgebildeter und weit verteilter Knobs, abweichender 
Maurer-Spalten Morphologie und der Unfähigkeit, das Wirts-Aktinzytoskelett umzuformen. 
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Zusammengefasst beschreiben unsere Ergebnisse eine Kaskade von Ereignissen, die mit dem 
Redox-Ungleichgewicht beginnt, das nicht infizierte hämoglobinopathische Erythrozyten 
aufweisen. Dieses oxidative Milieu stört den parasitären Proteinexport, die Remodellierung des 
Wirts-Aktins, die Ausbildung von Knobs und Maurer-Spalten, was ultimativ zu einer anomalen 
Präsentation von PfEMP1 auf der Zelloberfläche und einem verringerten Grad an Zytoadhäsion 
führt. Dies trägt dazu bei, die lebensbedrohlichen Folgen einer schweren Malaria zu verringern.  
 vi 
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1 Introduction 
1.1 Malaria Disease Burden 
Malaria is amongst the oldest and most influential of diseases, with written records of its 
characteristic cyclic fever stretching back to ancient civilisations in China (2700 BC), India and 
Egypt (1500 – 1600 BC) (Carter and Mendis, 2002; Cox, 2010). Many attempts at malaria 
control and eradication have been made over the years, both at the local and global levels, to 
varying degrees of success (Carter and Mendis, 2002; Nájera et al., 2011). In the year 2000, all 
members of the United Nations (UN) agreed to strive towards a set of eight goals, referred to 
as the Millennium Development Goals (MDGs), and achieve certain milestones by the year 
2015. One of this was Goal 6C: “Have halted by 2015 and begun to reverse the incidence 
of malaria and other major diseases.” (MDG-Monitor, 2016). 
Malaria exerts a great toll on the human population – not only in terms of morbidity and 
mortality, but also in terms of economic and social burden. Beyond the direct economic costs 
of medical treatments and income loss due to disease episodes, indirect costs such as changes 
in household behaviours, including schooling and migration, as well as macroeconomic effects, 
such as tourism and foreign investments, should also be taken into account when considering 
the impact of malaria as a disease (Sachs and Malaney, 2002). The influence of malaria on 
economic development is such that a comparison of average gross domestic product (GDP) 
between endemic and non-endemic countries shows more than a five-fold difference (US$1,526 
and US$8,268 respectively) (Gallup and Sachs, 2001). More importantly, this trend also applies 
to the rate of economic growth, where malaria endemic countries showing, on average, 0.4% 
economic growth rate per capita per year between 1965 – 1990, compared to 2.3% for their 
non-endemic counterparts. A 10% reduction in malaria index was also associated with a 0.3% 
rise in annual economic growth (Gallup and Sachs, 2001). 
With the UN declaring 17 “sustainable development goals” (SDGs) to succeed the MDGs 
which ended in 2015, global efforts to control and eradicate malaria will play a major role in 
how far we are able to achieve the SDGs by the target year of 2030, including the goal to end 
poverty, ensure healthy lives and well-being for all and promote sustainable economic growth 
(United Nations, 2017).    
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The world health organisation (WHO) estimated the number of malaria cases in 2016 to be 216 
million. Of the resulting 445,000 deaths, 70% are children under the age of 5 (WHO, 2017b). 
Moreover, previously published reports suggest that malaria may indirectly contribute to an 
increasing number of deaths through its interaction with other diseases such as HIV and 
invasive bacterial diseases (van Eijk et al., 2007; Scott et al., 2011; Church and Maitland, 2014; 
Cowman et al., 2016).  
There is a marked decrease in the number of malaria cases and mortality in 2016 compared to 
2010, where 237 million cases and 591,000 deaths were reported. This is reflected in the 18% 
reduction in incidence rate (the number of cases per 1000 population at risk) between 2010 – 
2016 (WHO, 2017b). The number of malaria endemic countries have also decreased from 106 
countries in 2000 to 95 countries in 2015 (Fig 1-1) (Phillips et al., 2017). Despite these 
encouraging news, the road to malaria eradication is still a long one, further complicated by 
emergence of insecticide and antimalarial drug resistance as well as climate change (Klein, 
2013; WHO, 2017b, a) 
Malaria is a disease centred in the tropical and subtropical zone, with 90% of cases and 91% of 
deaths reported in 2016 occurring in Africa (WHO, 2017b). This geographical distribution is 
partially governed by the effect of temperature on the development of Plasmodium parasites 
themselves as well as the availably of the female Anopheles vector (Gething et al., 2011; 
Phillips et al., 2017; Shapiro et al., 2017). Of the many members in the Plasmodium species, 
five causes malaria in human: Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale 
and Plasmodium malariae can also be transmitted by human while Plasmodium knowlesi is a 
zoonotic disease from long-tailed macaques (Macaca fascicularis) (Singh and Daneshvar, 
2013).  
Plasmodium falciparum, the deadliest of the five species, is most prevalent in Africa and South 
East Asia, whereas Plasmodium vivax has a wider geographical reach, including the colder 
temperate regions such as China and Korea (Fig 1-1) (Martens et al., 1999; Howes et al., 2016; 
Phillips et al., 2017; WHO, 2017b). The ability of Plasmodium vivax to survive in colder 
climates has been partially attributed to the presence of hypnozoites, a dormant hepatic stage 
which could escape treatment with standard antimalarial drugs and causes a relapse months or 
years after the initial infection (Campo et al., 2015). Plasmodium falciparum seems to be more 
sensitive to changes in temperature - a predicted rise of 2-3°C in global temperature could result 
in an additional 5% of the global population being at risk of malarial infection (Phillips et al., 
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2017; WHO, 2017a).  Not only that, the effects of climate change on other factors including 
length of seasons, amount of rainfall, vector availability, urbanisation, migration and increase 
in infrastructures such as dams and reservoirs would all contribute to changes in transmission 
intensities and the success of global malaria control strategies (Gething et al., 2011; Caminade 
et al., 2014).   
 
 
Figure 1-1 Global distribution of malaria in the year 2000 and 2015. 
The number of malaria endemic countries decreased from 106 in 2000 to 95 in 2015. Plasmodium falciparum 
cases are predominantly found in tropical areas such as Africa and South East Asia, whereas Plasmodium vivax 
has a slightly larger geological distribution, including countries with colder temperate climate such as china and 
korea. ‘Not applicable’ denotes countries which had not been separately surveyed. Figure reproduced from Phillips 
et al., (2017), with data from WHO, (2015b). 
 
1.2 Life cycle of Plasmodium falciparum 
Plasmodium falciparum goes through a complex series of sexual and asexual developmental 
stages in both the human host and the female Anopheles mosquito vector (Fig 1-2). The 
transmission begins with the bite of an infected mosquito, when approximately 100 sporozoites 
are deposited in the dermis of the human host. The sporozoites exhibit random gliding motility 
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until they encounter a blood vessel or a lymph node, while others remain in the skin (Amino et 
al., 2006; Jin et al., 2007; Ejigiri and Sinnis, 2009). Exiting the dermis through a process termed 
“cell traversal”, the sporozoites actively trespass through the endothelium of the blood vessel 
to be taken by the blood circulation, sweeping towards their next destination – the liver (Mota 
and Rodriguez, 2004; Amino et al., 2008).  
 
 
Figure 1-2 Life cycle of Plasmodium falciparum. 
Reproduced from Josling and Llinás, (2015). 
 
The slow rate of blood flow in the liver sinusoid allows the sporozoites to bind to the 
endothelium and interact with liver-specific, highly sulfated heparan sulfate proteoglycans 
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(HPSGs) found protruding through the fenestration into the sinusoid (Vaughan et al., 2008; 
Graewe et al., 2012). These interactions also trigger calcium signaling pathways, one of the 
factors believed to be involved in switching the sporozoites from “migratory” to “invasive” 
mode (Coppi et al., 2007) (Cowman et al., 2016). Individual sporozoites gain access to the liver 
parenchyma by transmigrating through Kupffer cells, resident hepatic macrophages, then 
continue to traverse through several hepatocytes before finally establishing a parasitophorous 
vacuole (PV) upon invasion of the final cell (Vaughan et al., 2008). The reason why the 
sporozoite traverses through several hepatocytes before finally infecting one remains under 
investigation, but it has been suggested that the traversal could both prime the sporozoite for 
invasion as well as render the hepatocytes more susceptible (Carrolo et al., 2003; Mota and 
Rodriguez, 2004). Another hypothesis is that it simply takes time to fully switched from 
migratory to invasive mode, and the cell traversal would continue to take place until the 
switching is complete (Graewe et al., 2012).      
After the sporozoite establishes itself inside a parasitophorous vacuole membrane (PVM), it 
undergoes changes from the elongated, motile sporozoite to a small, rounded trophozoite, 
called liver-stage (LS) or exo-erythrocytic form (EEF), before going through rounds of intense 
schizogony, producing up to 30,000 merozoites (Graewe et al., 2012). Membrane-bound 
vesicles termed merosomes containing these merozoites are found to bud from the hepatocytes 
into the sinusoid and directly release the merozoites into the circulation in order to avoid 
detection by Kupffer cells and other phagocytes (Sturm et al., 2006).  
Once a merozoite encounters an uninfected red blood cell, invasion is completed within 2 
minutes (Cowman et al., 2016). The steps include pre-invasion, active invasion and 
echinocytosis. Pre-invasion refers to the initial interaction of the merozoite with the erythrocyte 
which results in the deformation of the erythrocyte surface (Cowman et al., 2016). Active 
invasion then begins with the reorientation of the merozoite so that its apex faces the erythrocyte 
membrane. The binding of Plasmodium falciparum reticulocyte-binding protein homolog 5 
(PfRh5) to host receptor basignin initiates a series of downstream events, including the influx 
of calcium into the erythrocytes as well as the release of the microneme proteins such as the 
Rhoptry Neck Protein (RON) complex into the erythrocyte membrane (Weiss et al., 2015). The 
merozoite then invades the erythrocyte by establishing a Moving Junction through the binding 
of the surface protein Apical Membrane Antigen 1 (AMA1) to the RON complex (Delgadillo 
et al., 2016) and using the forces generated by the parasite actin-myosin motor to propel itself 
forward (Riglar et al., 2011). The parasitophorous vacuole membrane is believed to be formed 
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from the rhoptries content and membrane fusion at the posterior of the merozoite as it completes 
the active invasion seals the parasite inside the parasitophorous vacuole (Cowman et al., 2016). 
The brief formation of echinocytes after the active invasion phrase is believed to be due to the 
calcium influx instigated when PhRh5 binds to basignin at the beginning of the invasion process 
(Weiss et al., 2015). 
Once inside the host erythrocyte, the parasite undergoes an asexual replication cycle lasting 
approximately 48 h. This is the stage associated with most of the malaria pathophysiology such 
as fever, anaemia and further complications (Miller et al., 2002). During the intra-erythrocytic 
cycle, the parasite goes through three distinct stages: rings, trophozoite and schizont (Fig 1-2). 
The extensive remodelling of the host erythrocyte carried out by the parasite during this 
developmental stage will be covered in a later section of this thesis. At the end of the cycle, 
approximately 16 – 32 daughter merozoites are released – the parasite egress causing the 
destruction of the infected erythrocyte (Cowman et al., 2016). These daughter merozoites then 
continue the asexual replication cycle by infecting new red blood cells.     
During the intra-erythrocytic cycle, some parasites become committed to sexual development 
(Fig 1-2). Although the molecular mechanisms and factors behind this ‘switching’ remain 
unclear, increase in drug pressure as well as high parasitemia have been observed to increase 
gametocyte production (Price et al., 1996; Talman et al., 2004; Pietro, 2007). Five different 
stages of gametocyte maturation have been described for P. falciparum (Talman et al., 2004) 
and the immature gametocytes are found to sequester in the bone marrow during their 
development (Joice et al., 2014). Once the mature male and female gametocytes, termed micro- 
and macrogametocytes respectively, emerge into the blood stream, they are picked up by the 
Anopheles mosquito vector during a blood meal.  
The sexual development continues after the micro- and macrogametocytes are ingested by the 
mosquito. The abrupt decrease in temperature of approximately 5° C, the presence of 
xanthurenic acid (XA), a mosquito‐ derived molecule, as well as the increase in extracellular 
pH from 7.2 to about 8 are all reported triggers for the initiation of gametogenesis, which is 
when the microgametocytes exflagellate to produce motile microgametes and the 
macrogametocytes emerge from the erythrocytes and mature into rounded macrogametes 
(Billker et al., 1997; Billker et al., 1998; Pietro, 2007; Bennink et al., 2016). The fertilisation 
of micro- and macrogametes is followed by nuclear fusion and meiosis, resulting in a tetraploid 
zygote (Janse et al., 1986; Bennink et al., 2016). 
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The zygote matures into an elongated, motile ookinete containing micronemes, secretory 
organelles containing proteins involved in invasion, motility and tissue traversal. The ookinete 
exits the midgut lumen and traverses through several epithelial cells before exiting the 
epithelium through the basal side and transforms into an oocyst. The traversal of epithelial cells 
is believed to switch the ookinete from “traversal” to “sessile” mode (Aly et al., 2009). Laminin 
and other components of the mosquito’s basal lamina are also believed to be involved in the 
induction of the ookinete’s “sessile” mode and its development into an oocyst (Adini and 
Warburg, 1999).  
After several rounds of mitotic divisions, the oocyst grows to 50–60 μm in diameter and 
contains thousands of sporozoites, waiting to be released. The precise sequences and molecular 
mechanisms of sporozoite egress from the oocyst is still under investigation but a putative 
cystein protease named ECP1 (egress cysteine protease 1) is believed to be involved (Aly and 
Matuschewski, 2005; Aly et al., 2009). 
Once released into the hemocoel, the sporozoites are carried around the mosquito by the 
circulation (Rodriguez and Hernández-Hernández, 2004; Vlachou et al., 2006). Specific host 
receptors allow recognition and attachment to the basal lamina of the salivary glands, followed 
by transmigration through the acinar cells and exit into the salivary gland cavity (Pimenta et 
al., 1994; Aly et al., 2009). Gliding motility is reported to be involved in the migration of the 
sporozoite from the cavity into the salivary ducts, which allows transmission of the sporozoite 
to the human host upon injection of mosquito saliva while those remaining in the gland cavity 
are either lost or would have to be transmitted during future bites (Frischknecht et al., 2004; 
Rodriguez and Hernández-Hernández, 2004; Vlachou et al., 2006). The inoculated sporozoites 
then glide around the dermis until they encounter a blood vessel and thus the cycle begins again.  
 
1.3  Malaria Pathogenesis  
1.3.1 Clinical manifestations and pathogenesis 
Clinical manifestations and the outcome of malaria infection can vary depending on a 
combination of parasite and host factors, including parasite species, age, immune status and 
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genetics of the host, as well as interaction with other infections and access to care (Miller et al., 
2002; Bartoloni and Zammarchi, 2012a; Acharya et al., 2017).  
The initial presentation of malaria is rather unspecific, including flu-like symptoms such as 
fever, headaches, nausea, vomiting and diarrhoea (Bartoloni and Zammarchi, 2012a). The 
incubation period, the time between the infection and the onset of symptoms, can vary from 
approximately 9 – 30 days, depending on the Plasmodium species as well as host immune status 
and use of prophylactic anti-malarial drugs (Miller et al., 2002; Bartoloni and Zammarchi, 
2012a).  
Although fever is generally present since the initial onset of symptoms, they do not exhibit the 
trademark periodicity until approximately 5-7 days after infection, when the asexual replication 
cycle becomes synchronous. The cyclic nature of these febrile paroxysms also gave rise to the 
name “benign tertian”, “quartian” and “malignant subtertian” fevers for P.vivax, P.malariae  
and P. falciparum malaria, respectively (Carter and Mendis, 2002).  
There are three stages to the classical malaria paroxysm: a cold stage, a hot stage and a sweating 
stage (Bartoloni and Zammarchi, 2012b). As the name implies, the cold stage is when the 
patient feels extremely cold, starts shivering and their skin feels cold and dry. During these 10-
30 minutes, their body temperature gradually rises, reaching a peak of 39 – 41°C and the 
shivering stops as they enter the hot stage of the attack. Their skin now feels hot and dry, their 
face is flushed, and vomiting is common at this stage. Other symptoms including diarrhoea, 
severe headache and dizziness are also possible, including convulsions in younger patients. 
Within 2-6 hours after the onset, the patient enters the last stage of the attack, the sweating 
stage. After sudden and profuse sweating, lasting between 2-3 hours, the temperature falls and 
the patient feels well again, although sleepy and tired. The entire cycle lasts between 6 – 10 h 
and most often manifests in the late afternoon to evening (Bartoloni and Zammarchi, 2012b).   
These “mild” or “uncomplicated” malaria constitutes the majority of cases, with pathogenesis 
attributed to the release of parasitic factors and erythrocyte materials upon schizont rupture, 
triggering cytokine cascades responsible for many of the symptoms (Trampuz et al., 2003a; 
Fairhurst et al., 2012). However, sudden development of severe and life-threatening 
complications can occur in 1-3% of the cases. Despite timely treatment, the mortality rate for 
severe malaria is still very high: 20% in adult and 15% in children (Mackintosh et al., 2004; 
Bartoloni and Zammarchi, 2012b; WHO, 2017b). Without treatment, it is nearly always fatal. 
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“Severe malaria” is a complex mixture of overlapping syndromes involving multiple organ 
systems, including but not limited to: the central nervous system (cerebral malaria), 
haematopoietic system (severe anaemia) as well as systemic metabolic problems (acidosis and 
hypoglycaemia) (Trampuz et al., 2003b; Bartoloni and Zammarchi, 2012b). Occurring mostly 
in non-immune patients and children under the age of five infected by P. falciparum, these 
complications can rapidly develop and lead to death within hours or days (Trampuz et al., 
2003b).  
Enlarged liver and spleen are often observed in young children and non-immune adult patients, 
whereas acute renal failure is more common in adults (Bartoloni and Zammarchi, 2012b). 
Pregnant women are particularly prone to develop acute respiratory failure and primigravidae 
from endemic areas is classified as a high-risk population for pregnancy-associated malaria 
(PAM).   
Cytoadherance and sequestration of infected erythrocytes in the microvascular beds of vital 
organs such as the brain or the lungs is believed to be one of the key pathogenesis of severe 
malaria, as observed in post mortem brain sections (Mackintosh et al., 2004). Not only does the 
cytoadhesive parasitized erythrocytes produce physical obstruction to the blood flow, resulting 
in subsequence tissue hypoxia, the host immune and inflammatory response to the release of 
parasitic and cell components such as glycosylphosphatidylinositol (GPI), uric acid and haem 
upon schizont rupture further exacerbates the situation (Mackintosh et al., 2004; Fairhurst et 
al., 2012). Free haem-induced oxidative damage to the endothelium as well as the decrease in 
bioavailability of nitric oxide (NO) both contribute to the blood brain barrier (BBB) dysfunction 
(Figure 1.3) (Yeo et al., 2007; Miller et al., 2013). This could lead to coma, seizures and 
possible neurological effects (table 1) (Carter et al., 2006; Idro et al., 2006).   
Severe anaemia is another complication often associated with severe malaria. Although the 
increased haemolysis of infected erythrocytes upon merozoite egress as well as immune 
clearance through phagocytosis and destruction of “by-stander” uninfected erythrocytes due to 
damages caused by reactive oxygen species (ROS) released by infected RBCs all contribute to 
the reduction in circulating erythrocytes and thus anaemia, another important contributing 
factor is the reduced erythropoiesis in infected individuals (Fig 1-3) (Autino et al., 2012; Miller 
et al., 2013). Studies have shown that accumulation of hemozoin-laden monocytes in the bone 
marrow can inhibit erythropoiesis through the production of bioactive aldehydes such as 4-
hydroxynonenal (HNE), which has been shown to inhibit growth and differentiation of 
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erythroid cells (Skorokhod et al., 2010). Dysregulation of cytokines as a response to malaria 
infection can also have a negative effect on erythropoiesis (Table 1)(Haldar and Mohandas, 
2009; Perkins et al., 2011). Other factors such as malnutrition and co-infection with HIV, 
bacteremia or hookworms can also contribute to the pathophysiology (Calis et al., 2008; Autino 
et al., 2012).  
Several factors are likely to contribute to metabolic acidosis found in children with severe 
malaria, which precipitate clinically as respiratory distress (English et al., 1996). Poor tissue 
perfusion due to cytoadhesion and occlusion of the microvasculature by the infected 
erythrocytes increases the production of lactic acid through anaerobic glycolysis. Decrease in 
hepatic blood flow and thus liver clearance as well as increased lactic acid production by the 
parasite due to cytokine stimulation and decrease in gluconeogenesis due to circulating tumor 
necrosis factor all contribute to elevated level of lactate in the blood (Sasi et al., 2007; Miller 
et al., 2013). Severe anaemia and hypovolaemia also exacerbate the issue (Table 1, Fig 1-3).   
Primigravidae living in endemic areas are most at risk of pregnancy-associated malaria (PAM), 
due to the transient depression of cell-mediated immunity as well as the lack of antibodies 
against CSA-binding P. falciparum multigravidae have developed during their first pregnancy 
(Meeusen et al., 2001; Uneke, 2007; Autino et al., 2012). PAM is also associated with high 
morbidity for both mother and child, with the mother at risk of severe anaemia, miscarriage and 
pre-term delivery and the fetus at risk of low birth weight, intrauterine growth retardation and 
death (Table 1) (Agan et al., 2010; Falade et al., 2010; Bardaji et al., 2011). 
The preferential binding of the VAR2CSA variant of PfEMP1 (Plasmodium falciparum 
erythrocyte membrane protein 1) to low sulfated form of chondroitin-4-sulfate (C4S) found in 
the placenta causes an accumulation of parasitized erythrocytes in the intervillous space (Fried 
and Duffy, 1996; Achur et al., 2000) (Salanti et al., 2004; Viebig et al., 2005). The subsequent 
activation and infiltration of phagocytes as well as the release of pro-inflammatory cytokines 
and depositions of fibrin and hemozoins contribute to an increased thickness of the trophoblast 
basement membrane and thus impair the materno-fetal exchange of oxygen and nutrients, 
leading to poor pregnancy outcomes (Table 1) (Rogerson et al., 2007; Uneke, 2007; Autino et 
al., 2012). 
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Table 1 Pathophysiology and pathogenesis of severe and pregnancy-associated malaria.  
GPI - glycosylphosphatidylinositol; RBC - red blood cell. Adapted from Mackintosh et al., (2004). 
 
 
 
 
Syndromes Clinical features Disease mechanisms 
Severe 
anaemia 
Shock; impaired 
consciousness; 
respiratory distress 
Reduced RBC production (reduced erythropoietin 
activity, proinflammatory cytokines); increased RBC 
destruction (parasite-mediated, erythrophagocytosis, 
antibody and complement-mediated lysis) 
Cerebral 
complications 
(cerebral 
malaria) 
Impaired 
consciousness; 
convulsions; long-
term neurological 
deficits 
Microvascular obstruction (parasites, platelets, 
rosettes, microparticles); proinflammatory cytokines; 
parasite toxins (e.g. GPI) 
Metabolic 
acidosis 
Respiratory distress, 
hypoxia, tachypnea; 
acidaemia; reduced 
central venous 
pressure 
Reduced tissue perfusion (hypovolaemia, reduced 
cardiac output, anaemia); parasite products; 
proinflammatory cytokines; pulmonary pathology 
(airway obstruction, reduced diffusion) 
Other Hypoglycaemia; 
disseminated 
intravascular 
coagulation 
Parasite products and/or toxins; proinflammatory 
cytokines; cytoadherence 
Pregnancy-
associated 
Malaria 
(PAM)  
Placental infection; 
low birth weight and 
fetal loss; maternal 
anaemia 
Premature delivery and fetal growth restriction; 
placental mononuclear cell infiltration and 
inflammation; proinflammatory cytokines 
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Figure 1-3 Severe malaria pathogenesis 
Possible mechanisms of pathogenesis in severe malaria. Cerebral malaria: Cytoadhesion of infected RBCs to 
endothelial cells as well as resetting of uninfected RBCs causes obstruction to the blood flow, leading to tissue 
hypoxia and lactic acidosis. Release of free haemoglobin (Hb) from ruptured erythrocytes contributes to 
endothelial injury and dysfunction as it catalyses oxidative damage to the ECs, through ROS production, and 
consumes nitric oxide (NO). Without the anti-inflammatory and endothelial regulation action of nitric oxide, the 
inflammatory reaction to the sequestered iRBC is exacerbated, which causes damage to the blood brain barrier 
(BBB). Severe anaemia: Haemolysis of infected and bystander (uninfected) RBCs causes anemia that may be 
exacerbated by impaired erythropoiesis caused by parasitic toxins. Rosetting of both infected and uninfected 
erythrocytes meant that fewer RBC are available to carry oxygen around the circulation. Oxidative damage to 
uninfected RBC, caused by parasitic production of ROS, accelerates the senescence and removal of erythrocytes. 
Metabolic acidosis: Sequestration and rosetting reduce the blood flow. Lowered oxygen delivery causes hypoxia 
which increases lactic acid production through anaerobic glycolysis. Coupled with the increased metabolism of 
glucose into lactic acid by the parasites, this causes deep breathing states that lead to respiratory distress and failure. 
Adapted from Miller et al., (2013). 
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1.3.2 Recommended treatments and anti-malarial resistance 
In order to increase effectiveness and reduce the possibility of drug resistant parasite 
development, artemisinin-based combination therapies (ACTs) are the current recommended 
first line treatment for uncomplicated P. falciparum malaria. Artemisinin and its derivatives are 
exceptionally fast-acting drug effective against all stages of the intra-erythrocytic parasite and 
is shown to reduce severe malaria mortality by approximately 30% compared to quinine (White 
et al., 2014). However, their in vivo half-lives are typically only around 1 h in humans (Dondorp 
et al., 2009). ACTs combine artemisinins with longer acting partner drugs with a different mode 
of action to prevent recrudescence as well as delay the emergence of drug resistance (Tilley et 
al., 2016).  
A 3-day regimen of one of these 5 commercially available ACTs are recommended for use for 
children and adult, except pregnant women in the first trimester:  Ariplus® (artesunate-
sulfadoxine-pyrimethamine), Artekin® (dihydroartemisinin-piperaquine), Coarsucam® 
(artesunate-amodiaquine), Coartem® (artemether-lumefantrine) or Mefliam Plus® (artesunate-
mefloquine) (WHO, 2015a).   
A 7-day regimen of quinine – clindamycin combination therapy is recommended to pregnant 
women in their first trimester to reduce adverse risks on the developing foetus (WHO, 2015a).  
For severe malaria, an intravenous or intramuscular application of artesunate for at least 24 h is 
recommended. Once the patient can tolerate oral medication, a 3-day regimen of ATC is 
recommended (WHO, 2015a). 
Despite the use of ACTs, reports of artemisinin resistance have emerged from the Greater 
Mekong Subregion in South East Asia (Imwong et al., 2017). Resistance has now been 
documented against all classes of anti-malarial drugs currently in use, which proves a great 
challenge for malaria control and treatment (Wongsrichanalai et al., 2002; WHO, 2015a). This 
highlights the need for continued basic research in malaria biology, in the hope of finding new 
avenues for drug development as well as ways to control and eventually eliminate malaria.   
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1.4 Parasitic remodeling of host erythrocytes  
1.4.1 Erythrocytic membrane cytoskeleton 
The mature human erythrocyte is a terminally differentiated cell, specialized in oxygen and 
carbon dioxide transport. It contains no nucleus or other cell organelles and instead, filling 95% 
of its cytosol with haemoglobin (Haldar and Mohandas, 2007; Kanias and Acker, 2010). It 
measures 7-8 µm in diameter and is between 1.5 – 2.5 µm thick, with a high surface area to 
volume ratio and a biconcave discoid shape, both enabling optimal gas exchange (Keohane et 
al., 2015). However, to withstand large shear stresses in the arteries as well as survive repeated 
passage though narrow capillaries 2-3 μm in diameter, the erythrocyte requires membrane that is 
both mechanically stable and deformable (Haldar and Mohandas, 2007; Keohane et al., 2015; 
Gokhin and Fowler, 2016). 
The inner membrane surface of an erythrocyte is lined with a 2D, quasi-hexagonal meshwork 
containing spectrin, actin and associated proteins such as tropomodulin1, ɑβ-adducin and 
tropomyosins (Gokhin and Fowler, 2016). Erythrocyte spectrin is composed of two parallel 
chains of ɑ- and β-spectrin oriented in opposite directions, with a self-association site at the 
“head” end (Fig 1-4a). The nucleation site at the “tail” end facilitates electrostatic binding of 
individual ɑ- and β-spectrin chains, allowing the rest of the molecule to “zip” together into coils 
(Fig 1-5b) (Lux, 2016). ɑ- spectrin consists of 21 spectrin-type repeats, each formed by three 
ɑ-helices labelled A-C (Fig 1-4b), plus an ɑ0 partial repeat at the N-terminus, containing only 
the C-helix. β-spectrin consists of 16 repeats plus a β17 at the C-terminus, containing only A 
and B helices. The partial repeats ɑ0 and β17 binds together to create a spectrin dimer. Some 
of these repeats, indicated by stars in figure 1-5a, are reported to be unstable under physiological 
conditions (An et al., 2006). This may contribute to the molecule’s flexibility as the repeats 
may partially unfold as the erythrocyte deform (Johnson et al., 2007).  
A bigger contributor to the ability of erythrocyte membrane to withstand large amounts of 
distortion may be the weak association between the oligomers. Most of spectrin in the 
erythrocytes are found as ɑ2β2 tetramers but the weak self-association between oligomers allow 
tetramers to dissociate and reform when the membrane is distorted by shear forces, thus 
enabling the erythrocyte to deform as it travels through microcapillaries (An et al., 2002; 
Salomao et al., 2006).       
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Figure 1-4 Spectrin structure and binding sites. 
(a) Schematic diagram showing the orientation of the ɑ- and β- spectrin in a dimer, as well as mapped binding sites 
for known associated proteins. 4.2 – protein 4.2; Ca2+ - calcium ion; CH – calponin homology; 4.1R – protein 
4.1R; Lu-BCAM – Lutheran/basal cell adhesion molecule. PS denotes repeats which are able to bind phosphatidyl 
serine; blue star denotes repeats which are unstable at physiological temperature. (b) Structure of β8 and β9 spectrin 
repeats, displaying the triple helical structures of helix A, B and C in a Z-configuration (PDB 1S35). The junction 
between the repeats is formed by helix C from β8 and helix A from β9. Adapted from Lux, (2016)  
 
In native erythrocyte membrane preparations, the spectrin tetramers are said to be in a ‘folded’ 
configuration, with an end-to-end distance of between 35 – 100 nm (Fig 1-5a) (Swihart et al., 
2001; Nans et al., 2011). However, the tetramers can be extended up to 190 nm when spread in 
vitro, allowing for flexibility and extension during erythrocyte membrane deformation (Fig 1-
5a) (Shotton et al., 1979).    
The spectrin tetramers are connected to protofilaments of β-actin to form a quasi-hexagonal 
network of 2D lattices (Fig 1-5a). The length of the F-actin nodes is uniformly kept at 
approximately 37 nm, suggesting tight regulations by actin binding proteins (Fowler, 2013). 
These include capping at the pointed end by two tropomodulin 1 (Tmod1) molecules, capping 
at the barbed end by an ɑβ-adducin heterodimer and binding along its length by two 
tropomyosin isoforms, TM5b and TM5NM1, for stabilisation (Fig 1-5a) (Gokhin and Fowler, 
2016). These lateral lattices of spectrin-actin and associated proteins are vertically connected 
to the erythrocyte plasma membrane through interactions with ankyrin-B, which links spectrin 
tetramers to Band 3, an integral membrane protein (Fig 1-5) (Bennett and Baines, 2001; Gokhin 
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and Fowler, 2016). Other proteins which can link the actin-spectrin lattice to the lipid bilayer 
include αβ-adducin, which binds Band 3 as well as actin barbed ends, and protein 4.1R enhances 
spectrin-actin binding but can also bind to Band 3 and glycophorin-C (Fig 1-5b) (Anderson and 
Lovrien, 1984; Pasternack et al., 1985; Anong et al., 2009; Gokhin and Fowler, 2016).     
 
 
Figure 1-5 Current model of erythrocytic membrane cytoskeleton and associated proteins.  
(a) Schematic diagram illustrating cytoskeletal components in native and spread erythrocyte membranes. Spectrin 
tetramers are found in ‘folded’ configuration in native membranes, interconnecting with actin ‘nodes’ and actin 
binding proteins. The spread network reveals a quasi-hexagonal lattice. Tmod1 – tropomodulin 1; 
TM5b/TM5NM1 – tropomyosin isoforms. Adapted from Gokhin and Fowler, (2016) (b) A model of a cross-
section through the lipid bilayer of the erythrocytic membrane. GPA – glycophorin A; Prx2 – peroxiredoxin 2; 
GEC – Glycolytic enzyme complex; 4.2 – protein 4.2; GPB – glycophorin B; RhAG – Rh-associated glycoprotein; 
LW – Landsteiner-Wiener; GPC/D – glycophorin C/D; 4.1 – protein 4.1R; Glut 1 – glucose transporter 1. 
Reproduced from Lux, (2016). 
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1.4.2 Parasitic remodelling of host erythrocyte 
As the uninfected erythrocyte contains no intracellular organelles or protein export machineries, 
the Plasmodium parasite needs to substantially remodel the host cell in order to acquire the 
necessary nutrients for growth as well as export parasitic factors necessary for the development 
and completion of the intra-erythrocytic replication cycle, including immune evasion (Fig 1-
6a) (Haldar and Mohandas, 2007).     
In order to remodel the host cell to its liking, the parasite first need to establish its own protein 
export pathway. Now enveloped in a parasitophorous vacuole (PV), the parasite needs to export 
the protein across the parasitophorous vacuolar membrane (PVM) before it can target the 
protein to specific locations within the erythrocyte cytoplasm or to the erythrocyte plasma 
membrane (Przyborski et al., 2016). Protein transport across the PVM is shown to be mediated 
by a complex of proteins called PTEX (Plasmodium translocon of exported proteins) containing 
at least five members, although the individual components of the complex and their specific 
roles are still under investigation (Elsworth et al., 2014; Przyborski et al., 2016).  
Once the exported protein has successfully crossed the PVM, there is still the question of protein 
trafficking within the erythrocyte cytosol. Maurer’s clefts (MCs) are parasite-derived Golgi-
like membranous structures shown to act as a protein sorting station for many proteins exported 
to the erythrocyte surface, including the PfEMP1 (Plasmodium falciparum erythrocyte 
membrane protein 1) family of adhesins, best known for its role in cytoadhesion and 
pathogenesis (Fig 1-6c) (Mundwiler-Pachlatko and Beck, 2013). The Maurer’s clefts are shown 
to bud off from the PV shortly after infection, with many of the MC resident proteins being 
detectable from 2-6 h post invasion (Spycher et al., 2006; Gruring et al., 2011; McMillan et al., 
2013). Recent data from Cyrklaff et al., (2011) also reported vesicular trafficking between the 
MCs and the knobs, electron-dense protrusion on the erythrocytic surface involved in adhesin 
presentation (Fig 1-6d). The vesicles were shown to travel along elaborate networks of 
filamentous actin, which the parasite has mined and re-modelled from the erythrocyte 
cytoskeleton (Cyrklaff et al., 2011; Cyrklaff et al., 2012). 
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Figure 1-6 Plasmodium falciparum remodelling of host erythrocyte during the intra-erythrocytic stage.  
(a) Schematic depiction of parasite remodelling of host erythrocyte throughout the 48 h intra-erythrocytic stage. 
Maurer’s clefts are established in the host cytoplasm from approximately 12 h post infection (p.i.) and knobs and 
surface adhesin presentation are established by 24 h p.i. Adapted from Maier et al., (2009) (b) knob morphologies 
of infected HbAA erythrocytes as seen by SEM (top) and TEM (bottom). Scale bar 2µM for SEM and 0.5 µm for 
TEM. Blue arrow in the TEM image indicates an electron-dense knob on the erythrocyte membrane. Adapted from 
Fairhurst et al., (2012) (c) Adapted from Maurer’s cleft morphologies as seen by TEM on high-pressure frozen 
100 nm sections. Scale bar 100 nm. Adapted from Cyrklaff et al., (2016) (d) Surface-rendered reconstruction from 
cryo-electron tomograms of uninfected HbAA erythrocyte (i) and parasitized HbAA erythrocyte (ii). Scale bar 
100 nm. Erythrocyte actin cytoskeleton (yellow) in infected erythrocyte have been reorganised from short 
protofilaments in uninfected erythrocytes (i) into long filamentous network (ii), connecting the Maurer’s cleft 
(light blue) to the knob (red) at the plasma membrane (dark blue). Vesicles are seen to be associated with the actin 
filaments (light blue). Adapted from Cyrklaff et al., (2011). 
 
1.4.3 Knob, PfEMP1 and Cytoadhesion 
As shown in figure 1-6b, knobs are first identified as electron-dense protrusions on the surface 
of mature parasitized erythrocytes, with heights ranging from 2 – 20 nm and diameter ranging 
from 50-120 nm (Gruenberg et al., 1983; Quadt et al., 2012; Subramani et al., 2015). The main 
component of knobs is the aptly named knob-associated histidine rich protein (KAHRP), a 59-
72 kDa protein containing a PEXEL (Plasmodium export element) motif and an N-terminus 
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signal sequence (Fig 1-7a) (Triglia et al., 1987; Marti et al., 2004; Watermeyer et al., 2016). 
KAHRP is shown to interact with components of the host cytoskeleton, including spectrin, actin 
and ankyrin R (Oh et al., 2000; Pei et al., 2005; Rug et al., 2006; Weng et al., 2014), as well as 
the parasite adhesin PfEMP1(Ganguly et al., 2015) (Fig1-7a).  
KAHRP expression has been shown to be essential for cytoadhesion of parasitized erythrocyte 
under physiological flow condition, as kahrp- parasites were unable to cytoadhere to CD36, 
despite the presence of PfEMP1 on the erythrocytic surface (Crabb et al., 1997; Rug et al., 
2006). This suggests an important role for the correct display and presentation of adhesins in 
cytoadhesion.  
 
 
Figure 1-7 Knob architecture and PfEMP1 structure and binding domains.  
(a) A model of a cross-section through a “knob”, a parasite-derived protrusion on the surface of an infected HbAA 
erythrocyte. The knobs are shown to be involved in adhesin presentation. EPM – erythrocyte plasma membrane; 
PfEMP1 – Plasmodium falciparum erythrocyte membrane protein 1; KAHRP – knob-associated histidine rich 
protein. Reproduced from Helms et al., (2016) (b) PfEMP1 is a family of single-pass transmembrane proteins 
involved in cytoadhesion of infected erythrocytes to various host receptors. A typical structure of PfEMP1 consists 
of a highly conserved intracellular acidic terminal segment (ATS) and a highly variable extracellular domain, 
assembled from four basic building blocks in various configurations: N-terminal segment (NTS), Duffy-binding-
like domain (DBL), cysteine-rich interdomain region (CIDR) and C2 domains. Known interactions between 
specific domains and host receptors are shown. TM – transmembrane domain. Adapted from Smith et al., (2001). 
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The parasite takes up more room in the infected erythrocytes as it develops (Waldecker et al., 
2017). The insertion of various proteins and channels into the erythrocytic membrane causes 
membrane stiffening as well as potential recognition of parasitic proteins by the host immune 
system (Maier et al., 2009; Watermeyer et al., 2016). Circulating erythrocytes need to be able 
to pass through the splenic interendothelial slit (IES) in order to avoid clearance - late stage 
parasitized erythrocytes are simply too stiff to pass this test (Pivkin et al., 2016). In order to 
avoid detection and elimination in the spleen, the parasite export and display adhesins from the 
PfEMP1 family, which can interact with host receptors on the endothelial cells and allow the 
parasitized erythrocyte to sequester in the microvasculature of various organs (Maier et al., 
2009; Tilley et al., 2011; Helms et al., 2016). Inadvertently causing obstruction of blood flow, 
leading to hypoxia and tissue necrosis, as well as endothelial cell activation, cytoadhesion has 
often been implicated in the pathogenesis of severe malaria (Mackintosh et al., 2004; Miller et 
al., 2013).  
PfEMP1, the parasitic protein responsible for cytoadhesion, is encoded by 60 different members 
of the var gene family. The protein size varies from 200 – 350 kDA but there are some 
conserved structural features, namely the N-terminal segment (NTA), followed by a semi-
conserved head structure containing Duffy Binding Like domains (DBL; α-ɛ) and cysteine-rich 
interdomain regions (CIDR; α-γ), a C2 domain, a transmembrane domain (TM) and a conserved 
intra-cellular acidic terminal segment (ATS) (Fig 1-7b) (Kraemer and Smith, 2006; Pasternak 
and Dzikowski, 2009). The highly variable extracellular domain allows for interactions with a 
multitude of host receptors, including CD31, CD36, intercellular adhesion molecule 1 (ICAM 
1), P-selectin and chondroitin‐ 4‐ sulfate (CSA) (Rowe et al., 2009; Tilley et al., 2011; Helms 
et al., 2016). 
Despite the variation in the extracellular domain and the binding partner, only one variant of 
PfEMP1 is expressed on each infected erythrocyte at a given time. How the parasite controls 
the PfEMP1 expression so tightly is still a matter of ongoing investigation, although it has been 
speculated that epigenetic mechanisms might be involved as the majority of the parasite in each 
new cycle express the same var gene, hinting at possible role of genetic imprinting (Scherf et 
al., 1998; Craig and Scherf, 2001; Scherf et al., 2008).  
Although what causes the parasite to switch the expression from one PfEMP1 variant to another 
is also still under investigation, the biological advantage of “allelic exclusion” is clear – to 
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minimise exposure of its antigenic repertoire means more successful immune evasion and thus 
a higher chance of transmission to a new host (Pasternak and Dzikowski, 2009). 
 
1.5 Haemoglobinopathic erythrocytes and protection against severe 
malaria 
1.5.1 Haemoglobinopathies 
Haemoglobin (Hb) is a metalloprotein adapted for oxygen transport, with a heme prosthetic 
group bound to a pocket in each of the four globin monomers (Hardison, 1996). Adult 
haemoglobin (HbA – α2β2) is a heterotetramer consisting of two α- and two β-globin chains, 
which allows the molecule to effectively bind oxygen at high partial pressure in the lungs and 
then release it in the tissue with lower oxygen partial pressure (Weatherall, 2010).  
Haemoglobinopathies are inherited disorders of the globin gene and can be broadly divided into 
two categories: the thalassemais affect the amount of protein output, while the Hb variants 
affect the structures of the proteins (Trent, 2006). Table 2 summarises some key features of the 
most common haemoglobinopathies, including their geographical distributions and genotypes.   
In sickle cell haemoglobin (HbS), a single amino acid substitution at position 6 of the β-globin 
chain causes glutamate to be substituted by valine. This compromises its ability to stay soluble 
at high concentration, thus resulting in self-aggregation of deoxy HbS molecules under low-
oxygen conditions (Weatherall, 2010). The resulting rope-like fibres can distort the cell shape 
into the distinctive “sickle” or “half-moon” shapes. HbS cells also have decreased elasticity and 
increased tendency to adhere to endothelial cells, resulting in intermittent vaso-occlusive events 
(Rees et al., 2010). The shortened lifespan of the cells is also said to contribute to chronic nitric 
oxide depletion, in addition to anaemia, due to the constant presence of haem released after 
intravascular haemolysis, resulting in pulmonary hypertension (Gladwin et al., 2004; De Castro 
et al., 2008).   
In parts of sub-Saharan Africa, Middle East and India, the allele frequency of HbS could be as 
high as 40% (Flint et al., 1998; Bauduer, 2013). This strongly correlates with the geographical 
distribution of malaria, suggesting a co-evolutionary selective pressure (Williams and 
Weatherall, 2012). 
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Comparatively, HbC has emerged much more recently, with its geographical reach only limited 
to West Africa – the allele frequency is up to 20% but only in central Ghana and Burkina Faso 
(Serjeant, 2013). A point mutation leading to an amino acid substitution at the same position as 
found in HbS, position 6 of β-globin gene, caused a negatively charged glutamic acid to be 
exchanged for a positively charged lysine (Feeling-Taylor et al., 2004). This resulted in 
formation of intracellular crystals and induced erythrocyte dehydration (Nagel et al., 2003). 
 
Table 2 The Major Haemoglobinopathies at a glance. Reproduced from Taylor et al., (2013) 
 
 
1.5.2 Epidemiological evidence of protection 
The “malaria hypothesis” was hypothesized by J.B.S. Haldane in 1949, stating that infectious 
diseases could be one of the naturally selective factors driving evolution, using the co-
occurrence of β-thalassemia and malaria in Mediterranean countries as an example 
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(Dronamraju et al., 2006). This was empirically shown in 1954 by Anthony Allison (1954), 
who was able to demonstrate a decreased malaria incidence in children with sickle cell traits 
compared to their peers without the traits.  
In a meta-analysis of recent publications, Taylor et al., (2012) was able to conclude that HbAS, 
HbCC, HbAC, homozygous α-thalassaemia and heterozygous α-thalassaemia conferred 
significant protection against severe malaria – but only HbAS was associated with protection 
against uncomplicated malaria. These findings do reflect the individual studies reported, where 
children carrying HbAS was shown to suffer fewer episodes of both severe and uncomplicated 
malaria, with a 10-fold lower risk of mortality in the former case (Aidoo et al., 2002; Cyrklaff 
et al., 2012; Fairhurst et al., 2012). HbC is also reported to protect against symptoms of severe 
malaria but not uncomplicated malaria (Agarwal et al., 2000). 
 
1.5.3 Aberrant ultrastructural morphologies, host actin remodelling 
and reduced cytoadhesion in parasitized haemoglobinopathic 
erythrocytes 
Regardless of the epidemiological evidence, the molecular mechanisms behind the protection 
of haemoglobinopathic erythrocytes against severe malaria have yet to be elucidated (Taylor et 
al., 2013).  
Recent studies by Fairhurst et al., (2005), Cholera et al., (2008) and Cyrklaff et al., (2011; 2016) 
have found that both parasitized HbS and HbC displayed aberrant knobs and Maurer’s cleft 
morphologies, as well as inability to reorganise host actin cytoskeleton (Fig 1-8). The 
cytoadhesive phenotype as well as levels of PfEMP1 surface presentation were also reduced in 
infected HbS and HbC, relative to HbAA.   
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Figure 1-8 Aberrant ultrastructural morphologies in infected HbAC and HbAS erythrocytes 
SEM and TEM showing enlarged and irregularly distributed knob morphologies in infected HbAC and HbAS. 
Blue arrows indicae knobs in the TEM images. The Maurer’s clefts (MCs) were malformed and the parasite was 
unable to reorganise host actin cytoskeleton (yellow) into elaborate filamentous networks as seen in infected HbAA 
(cryo-EM). The following colours were used for specific ultrastructures in the surface-rendered view of cryo-EM: 
MCs -light blue, actin cytoskeleton - yellow, knobs – red and plasma membrane – blue. Scale bars – SEM 2 µm, 
TEM (knobs) 0.5µm, TEM (MCs) 100 nm, Cryo-EM 100 nm. Adapted from Cyrklaff et al., (2011); Fairhurst et 
al., (2012); Cyrklaff et al., (2016). 
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In trying to find a common mechanism behind these morphological phenotypes, a hypothesis 
was generated around the effects of pro-oxidative environment and reactive oxygen species 
produced by the unstable HbS and HbC, which are prone to auto-oxidation (Hebbel et al., 1982; 
Macdonald and Charache, 1982; Hebbel et al., 1988; Krause et al., 2012). Actin cytoskeleton 
has been found to be destabilised in the presence of oxidatively damaged haemoglobin such as 
irreversible hemichromes (Jarolim et al., 1990; Cyrklaff et al., 2011). This would affect both 
the Maurer’s cleft morphologies as well as the trafficking of PfEMP1 to the erythrocyte surface, 
resulting in the final phenotypical outcome of reduced cytoadhesion and thus reduced malaria 
pathogenesis. 
 
1.6 Overall aim  
This thesis comprises of three distinct but interrelated projects, aimed to further our 
understanding of the molecular mechanisms behind the ability of haemoglobinopathic 
erythrocytes to protect their hosts against severe complications in malaria.   
Project I: Visualisation of erythrocyte cytoskeletal proteins by super-resolution 
microscopy 
Project I aims to establish a working protocol for imaging of actin and spectrin in erythrocyte 
samples using direct stochastic optical reconstruction microscopy (dSTORM). 
Project II: Kinetics of protein export in infected haemoglobinopathic erythrocytes 
Project II aims to investigate differential export kinetics of selected parasitic proteins in infected 
HbAA and haemoglobinopathic erythrocytes. 
Project III: Oxidative pre-treatment of uninfected erythrocytes to mimic the protective 
phenotypes of haemoglobinopathic erythrocytes 
Project III aims to investigate the effect of an induced pro-oxidative environment on the parasite 
morphologies and cytoadhesion phenotype.  
By better understanding the molecular mechanisms which underpins the protective phenotype 
of haemoglobinopathic erythrocytes against severe malaria, we hope to explore new venues of 
research into novel clinical interventions which could circumvent the rise of drug-resistant 
parasites.   
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2 Material and Methods 
2.1  Materials 
2.1.1  Equipment 
Equipment Model Company 
Analytical balance ABT 120-5DM Kern & Sohn, Balingen, Germany 
Autoclave ABT 120-5DM 
2540 EL 
Kern & Sohn, Balingen, Germany 
Tuttnauer, Breda, The Netherlands 
Balance  Sartorius GmbH, Göttingen 
Centrifuge Biofuge fresco 
 
Biofuge pico 
 
Megafuge 1.0 R 
Megafuge 2.0 R 
Thermo Fisher Scientific, Dreieich, 
Germany 
Thermo Fisher Scientific, Dreieich, 
Germany 
Heraeus, Hanau, Germany 
Heraeus, Hanau, Germany 
Confocal microscope LSM510 Zeiss, Jena, Germany 
Flow cytometer FACSCalibur Becton and Dickinson, Heidelberg, 
Germany 
Syringe pump 55-2316 Harvard Apparatus, Holliston, MA 
Freezer -20ºC LGex 3410 MediLine Liebherr, Biberach, Germany 
Freezer -80ºC HERAfreeze Thermo Fisher Scientific, Dreieich, 
Germany 
Fridge LKexv 3910 MediLine Liebherr, Biberach, Germany 
Heating block NeoBlock Mono I NeoLab, Heidelberg, Germany 
High precision pump 55-2316 Harvard Apparatus, MA, USA 
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Equipment Model Company 
AL-4000 World precision instruments, 
Florida,USA 
Ice machine  Ziegra, Isernhagen, Germany 
Incubator Heraeus Cytoperm2 
 
HeraCell 
Thermo Fisher Scientific, Dreieich, 
Germany 
Thermo Fisher Scientific, Dreieich, 
Germany 
Inverted microscope Zeiss Axio Observer Z1 
DM IL 
Carl Zeiss, Oberkochen, Germany 
Leica, Wetzlar, Germany 
Light optical microscope Axiolab Zeiss, Jena, Germany 
Liquid nitrogen tank MVE Cryosystem 6000 
 
LS 6000 
RS Series 
Thermo Fisher Scientific, Dreieich, 
Germany 
Taylor-Wharton, Husum, Germany 
Taylor-Wharton, Husum, Germany 
Magnetic sorter VarioMACS Miltenyi Biotec, Bergisch 
Gladbach, Germany 
Magnetic stirrer RCT 
COMBIMAG RCH 
IKA, Staufen, Germany 
IKA, Staufen, Germany 
MiliQ water system Purist ultrapure Rephile, Germany 
Particle counter Z1 Beckman Coulter, Krefeld, 
Germany 
pH meter pH 7110 WTW, Weilheim, Germany 
Pipets P2, P10, P20, P1000 Gilson,  Limburg an der Lahn, 
Germany 
Pipetus Forty\Standard Hirschmann, Eberstadt, Germany 
Adaptors for silicon tubing Elbow connector Ibidi, München, Germany 
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Equipment Model Company 
Luer connector male 
Luer lock connector 
male 
Luer lock connector 
female 
Female luer lock 
coupler 
Ibidi, München, Germany 
Ibidi, München, Germany 
 
Ibidi, München, Germany 
 
Ibidi, München, Germany 
Silicon tubing   1.6 mm 
 
Ibidi, München, Germany 
Scanning electron microscope Leo Gemini 1530 Carl Zeiss Oberkochen, Germany 
Shaker KS 501 digital IKA, Staufen, Germany 
Spectrophotometer UVIKON 923 Kontron instruments, Munich, 
Germany 
Sputter coatter EM MED 020  Leica, Wetzlar, Germany 
Sterile work bench Herasafe 
 
SterilGard Class II 
Thermo Fisher Scientific, Dreieich, 
Germany 
The Baker company, Sanford, ME, 
USA 
Thermocycler Labcycler Sensoquest, Göttingen, Germany 
UV chamber GS Gene linker Bio-Rad, München, Germany 
UV table TFX-35M Vilber Lourmat, Eberhardzell, 
Germany 
Vortex Genie 2 Scientific Industries, Bohemia, 
NY, USA 
Waterbath MP Julabo, Seelbach, Germany 
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2.1.2  Disposables 
 
Disposable Company 
μ-slide, 8-chamber    Ibidi, München, Germany 
96 well cell culture plates               Greiner bio one, Frickenhausen, Germany 
Aluminium foil               Carl Roth, Karlsruhe, Germany 
Cellstar Tubes               Greiner bio one, Frickenhausen, Germany 
Centrifuge bottles Nalgene 500 ml           Thermo Fisher Scientific, Dreieich,  
    Germany 
Clingfilm Saran             Dow, Schwalbach, Germany 
Cuvettes Gene Pulser           Bio-Rad, München, Germany 
Filters Millex GS (0,2 μm)           Merck  Millipore, Darmstadt, Germany 
Filter systems 500 ml             Corning, Kaiserslautern, Germany 
Gloves TouchNTuff           Ansell, München, Germany 
MACS CS column    Miltenyi Biotec, Bergisch Gladbach, 
    Germany 
Micro tubes 1.5 ml              Saarstedt, Nümbrecht, Germany 
Parafilm               Bemis, Londonderry, UK 
Petri dishes (10 ml diameter)               Greiner bio one, Frickenhausen, Germany 
Petri-dishes (25 ml diameter)              Greiner bio one, Frickenhausen, Germany 
Pipette Tipps     Corning, Kaiserslautern, Germany 
Plastic pipettes (1 ml; 2 ml; 5 ml; 10 ml; 25 ml) Corning, Kaiserslautern, Germany 
Precision wipes (11x21cm)    Kimberly Clark, Mainz, Germany 
Polypropylene tubes (14 ml)    Greiner bio one, Frickenhausen, Germany 
PyroMark Q96 Plate Low    QIAGEN, Hilden, Germany 
Disposable Scalpel    Feather, Osaka, Japan  
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Transfer pipettes    Sarstedt, Nümbrecht, Germany 
2.1.3 Kits 
Kits Company 
Ambion DNA-free kit Invitrogen - Thermo Fisher Scientific, 
Vilnius, Lithuania 
SuperScript III First Strand Synthesis   Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
Taq DNA polymerase kit Qiagen, Düsseldorf, Germany 
Gel extraction kit QIAGEN, Hilden, Germany 
PCR purification kit QIAGEN, Hilden, Germany 
2.1.4 Antibodies 
Antibodies Company 
Anti β-tubulin  Invitrogen - Thermo Fisher 
Scientific, Vilnius, Lithuania 
Anti spectrin  Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
Anti-VAR2CSA Gifted from Ali Salanti 
2.1.5 Fluorescent Dyes 
Dye Ex/Em Company 
Alexa Fluor 488 490/525 Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
Alexa Fluor 532 532/554 Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
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2.1.6 Buffers, media and solutions 
Buffer / Media / Solution Composition / Recipe 
Complete culture medium RMPI 1640 medium supplemented with 2 mM L-
glutamine, 25 mM HEPES, 100 µM hypoxanthine, 20 
µg/ml gentamicin and 10% (v/v) human serum. 
Freezing solution 6.2 M Glycerol, 140 mM Na-Lactat, 0.5 mM KCl, pH 
7.2 adjusted with 0.5 M of NaHCO3 at pH 9. 
Thawing solution I 12% (wt/v) sodium chloride. 
Thawing solution II 1.8% (wt/v) sodium chloride. 
Thawing solution III 0.9% (wt/v) sodium chloride, 0.2% (wt/v) glucose. 
Sorbitol lysis solution 
 
280 mM D-sorbitol, 5 mM HEPES, pH 7.4. 
(300 mOsm). Heat sterilized. 
MACS buffer PBS, 2mM EDTA, 0.05% (wt/v) BSA 
Gelatin solution 0.5% (wt/v) gelatin (from porcine skin type A) was 
dissolved in RPMI 1640 supplemented with 2 mM L-
glutamine and 25 mM HEPES for 30 min at 56°C. 
Alexa Fluor 647 650/665 Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
SiR Actin 652/674 Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
Phalloidin-Alexa Fluor 488 490/525 Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
Propidium Iodide 493 / 636  Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
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Buffer / Media / Solution Composition / Recipe 
RMPI incomplete RMPI 1640, 2 mM L-glutamine and 25 mM HEPES. 
Adhesion medium RMPI 1640, 2 mM L-glutamine and 25 mM HEPES, 
0.05% (wt/v) pH 7.2. 
Glucose solution for dSTORM 100 mg glucose, 900 µL PBS, 100 µL glycerin 
Enzyme solution for dSTORM 1 mg glucose oxidase (Sigma G2133-50KU), 20 µL 
Tris-HCl pH 7.5 (1M Stock), 25 µL KCL (1M Stock), 
2 µL catalase from bovine liver (C100-50MG), 4 µL 
TCEP/DTT (1M Stock), 0.5 mL glycerine, 0.45 mL 
water 
MEA/PBS for dSTORM 1M stock solution (freshly prepared from salt stock; 
MEA: cysteamine hydrochloride 
(Sigma M6500-25G)) 
dSTORM imaging buffer 
(Buffer I)  
950 µl PBS, 50 µl freshly prepared MEA/PBS,  
15 µl of 1M KOH 
dSTORM imaging buffer 
(Buffer II)  
900 µl PBS, 100 µl freshly prepared MEA/PBS  
15 µl of 1M KOH, 50 µl Enzyme solution 
dSTORM imaging buffer 
(Enzyme solution)  
1 mg glucose oxidase (Sigma G2133-50KU) 
20 µl Tris-HCl pH 7.5 (1M Stock) 
25 µl KCL (1M Stock) 
2 µl catalase from bovine liver (C100-50MG) 
4 µl DTT (1M Stock)  
0.5 ml glycerin 
0.45 ml water 
Hypotonic solution A 1:10 dilution of RPMI 1640 and distilled water, 20 
μg/ml leupeptin, 20 μg/ml pepstatin 
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Buffer / Media / Solution Composition / Recipe 
Hypotonic solution B 1:5 dilution of RPMI 1640 and distilled water, 20 
μg/ml leupeptin, 20 μg/ml pepstatin 
 
2.1.7 Primers  
Target Primers Sequence 
Cyclophilin PFE0505w_Fwd 5' AAACGGGAGATCCTTCAGGT 
 PFE0505w_Rev 5' AAGGACATGGGACAGTGGTT 
var2csa PFL0030c_ex_Fwd 5' GACGCGAAACGAAACCGTAA 
 PFL0030c_ex_Rev 5' ACTACTTGGGCCACAATTTTTTG 
 
2.1.8 Software  
Program   Company 
SigmaPlot 13.0     Systat, San Jose, CA, USA   
LSM imaging software       Zeiss, Jena, Germany 
FIJI      (Schindelin et al., 2012) 
RapidSTORM 3.3    (Wolter et al., 2012) 
Andor Solis 4.16    Andor, Belfast, Northern Ireland   
SuReSim     (Venkataramani et al., 2016) 
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2.2  Methods 
2.2.1 Ethical Clearance 
The text of the following paragraph has been taken from Kilian et al., (2015) and has originally 
been written by myself: 
All studies were approved by both the ethical review boards of Heidelberg University, 
Germany, and the Biomolecular Research Center (CERBA/Labiogene) at the University of 
Ouagadougou, Burkina Faso. Written informed consent was given by all blood donors. 
2.2.2 Blood collection and genotyping 
Haemoglobinopathic erythrocytes (HbAC and HbAS) were donated in Burkina Faso and 
immediately shipped at 4° C to Heidelberg University for further analysis. Fetal erythrocytes 
were obtained from the umbilical cord following delivery at Heidelberg University Hospital.  
The plasma and buffy coat were removed and discarded after 10 min of centrifugation at 800 g 
(RT). The erythrocytes were washed three times with three volumes of RPMI-1640 medium 
and stored at 4°C. Erythrocytes were used within two weeks after collection. Haemoglobin 
genotypes were performed by the Kooperatives Speziallabor of the Heidelberg University 
Hospital.  
2.2.3 Methods for Plasmodium falciparum cell culture 
2.2.3.1 In vitro culture of P. falciparum 
Throughout this study, the P. falciparum strains FCR3-CSA and HB3 were kept in continuous 
cultures as previously described (Trager and Jensen, 1976). The haemoglobin variant of 
uninfected erythrocytes used in the culture were sometimes varied according to the 
experimental setup. Briefly, cultures were maintained in a Petri dish of either 10 or 35cm 
diameter with 3.5% hematocrit. The medium used was RPMI 1640 supplemented with 2 mM 
L-glutamine, 25 mM HEPES, 100 μM hypoxanthine, 20 μg/ml gentamycin, 5% albumax and 
5% human heat-inactivated A-positive serum. AB-positive serum was substituted in case of 
cultures containing HbS or HbC blood.  
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Cultures were incubated at 37°C under controlled atmospheric conditions of 5% O2, 3% CO2, 
92% N2 and a humidity of 96%. The parasitemia was kept below 5%.   
 
2.2.3.2 Monitoring of parasitemia and intra-erythrocytic 
developmental stage  
2% Giemsa (BDH Laboratory Supplies) and thin blood smears were used to determine the 
developmental stage and parasitemia of the parasite cultures. A drop of the culture was collected 
from the bottom of the petri dish and spread onto the glass slide. After 10 sec of fixation in 
100% Methanol, the slide was stained in 2% Giemsa solution for 15 minutes and rinsed with 
deionised water. The stained blood smear was evaluated with a light microscope. 
2.2.3.3 Synchronization of Asexual Stages 
5% D-sorbitol was used for synchronisation and selection of ring stage parasites as previously 
described (Lambros and Vanderberg, 1979). Briefly, the resuspended culture is centrifuged at 
1900 rpm for 2 min and the supernatant is discarded. The pellet is resuspended in 5 volumes of 
5% sorbitol. The suspension is gently mixed and incubated at 37°C for 5 min. The suspension 
is centrifugated for 2 min at 1900 rpm, the sorbitol solution discarded and the pellet resuspended 
in 14 ml cell culture medium. The synchronised pellet is re-cultured after another round of 
washing with the medium.  
The activation of the New Permeability Pathway (NPPs) during the trophozoite stage allows 
uptake of sorbitol, which leads to hypotonic lysis during the washing step. Ring stages younger 
than 18 h p.i. are retained after the treatment. Tighter synchronisation can be achieved through 
repeated synchronization after 4–6 h. 
  
2.2.3.4 Gelatin sedimentation 
Gelatin sedimentation can be used to separate P. falciparum infected erythrocytes according to 
their densities, in that the schizont and trophozoite-stage have lower densities than ring-infected 
and uninfected erythrocytes, causing them to take longer to sediment (Goodyer et al., 1994). 
The parasite culture is resuspended and centrifuged for 2 min at 1900 rpm at room temperature. 
After removal of the medium, the pellet is resuspended in 9x volume of 0.5% gelatin for 1 h 
and kept at 37 °C. After the allotted time, the supernatant containing late-stage parasites was 
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carefully transferred to a new falcon tube and centrifugated for 2 min at 1900 rpm to pellet the 
parasitized erythrocytes. The cells were washed with RPMI 1640 and re-cultured.  
 
2.2.3.5 Selection of CSA adhesive P. falciparum infected erythrocytes 
Selection and enrichment of CSA binding parasites were carried out as previously described 
(Alkhalil et al., 2000). Briefly, sterile tissue culture flasks were coated with 30mg/ml CSA in 
PBS and incubated overnight at 4°C. Mature stage parasites were enriched via gelatin floatation 
as described above. In parallel, the flask was washed and blocked with 1% BSA for 1 h. The 
parasites were resuspended in adhesion medium and incubated on the CSA-coated flask for 1 
hour at 37°C. Non-adherent cells were gently removed with the supernatant and the flask was 
washed 5-10 times with adhesion medium using a gentle rocking motion. The last wash should 
be strong and the supernatant is taken to be centrifuged for 2 min at 1900 rpm to pellet the CSA-
adhesive parasites. The pellet is used for inoculum of further parasite culture. As the binding 
strength is reported to gradually decrease over time, the process was repeated once every 3 
weeks to maintain the adhesive phenotype (Achur et al., 2008). 
 
2.2.3.6 Purification of late stages P. falciparum through magnetic 
column 
The Magnetic Activated Cell Sorter (MACS) system was used to purify P. falciparum 
trophozoite and schizont. Briefly, the MACS CS column was washed twice with MACS buffer 
and inserted into the VarioMACS separator. The culture was resuspended, applied to the top of 
the column and allowed to flow through with the flow rate of 1 drop every 3 sec. The column 
was washed with MACS buffer until the flow through was clear. The column was then removed 
from the separator and the enriched late stages iRBC were eluted using 10 ml of MACS buffer. 
The cells were centrifuged at 1900 rpm for 2 min and to sediment the pellet and then further 
processed according to different experimental requirements.       
 
2.2.3.7 Infection of haemoglobinopathic erythrocytes 
Tightly synchronized parasites (±6 h) at trophozoite stage were magnetically enriched as 
described above. The purified iRBCs were washed with RPMI culture medium containing AB 
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serum and then added to fresh HbAS or HbAC erythrocytes to a parasitemia of 1-2% and 3.5% 
haematocrit for cell culture. Parasite invasion and development were monitored with thin blood 
smears. Paired and parallel infection of haemoglobin AA erythrocytes were used as control. 
 
2.2.3.8 Cryopreservation of P. falciparum 
The parasite culture was resuspended and centrifuged at 1900 rpm for 2 min and the supernatant 
discarded. Slowly, 1/3 pellet volume of freezing solution was added drop by drop and mixed 
carefully with the infected erythrocytes. The mixture was incubated at room temperature for 5 
min and then a further 4/3 volume of freezing solution were slowly added to the sample. The 
sample was transferred to 2 cryogenic vials that were kept at -80ºC for short term storage. The 
vials were transferred to liquid nitrogen tanks for long term storage of the samples. 
 
2.2.3.9 Thawing of P. falciparum 
The frozen cryovial was gently thawed and 5-7 drops of 12% NaCl solution was added over 
5 min while thoroughly mixing the suspension after every drop. The mixture was then 
transferred to a 15 ml falcon tube and 4.5 ml of 1.6% NaCl solution was slowly added over 
5 minutes while mixing. After centrifugation at 1900 rpm for 4 minutes, the supernatant was 
removed and the pellet was resuspended in 4.5 ml of 0.9% NaCl + 0.2% Dextrose solution. 
After centrifugation for 4 minutes at 1900 rpm, the supernatant was removed and the pellet was 
resuspended in 13 ml cell culture medium for cultivation. 
2.2.4 Microscopy 
2.2.4.1 Direct Stochastic Optical Reconstruction Microscopy (dSTORM) 
2.2.4.1.1 Cleaning and functionalisation of glass surface 
2M NaOH was pipetted into the imaging chamber and incubated for 20 minutes. After washing 
with PBS (3 x 5 min), the chamber was then incubated with 0.01% Poly-L-Lysine for 1 h, 
followed by 200µg/µl concanavalin A for 1 h before sample application. The chamber was kept 
moist at all times. 
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2.2.4.1.2 Sample preparation 
Uninfected and MACS-purified, infected trophozoite-stage HbAA erythrocytes were fixed with 
4% PFA and 0.0075% GA for 30 min, washed with PBS and briefly perforated with 5AU of 
activated streptolysin-O (SLO) in order to release some haemoglobin content and reduce 
background fluorescence. The samples were then labelled with primary mouse anti-spectrin 
antibody and anti-mouse Alexa Fluor 647 secondary antibody, immobilised on pre-coated 
glass-bottom ibidi µ-slides and imaged at 63x magnification with Buffer II as blinking buffer. 
For actin imaging, the same sample preparation protocol was followed but Phalloidin-
conjugated Alexa Flour 488 was used instead of the primary and secondary antibodies. 
2.2.4.1.3 Image acquisition 
2D-STORM imaging was carried out on a custom-built set up, as described by Flottmann 
(2014). A minimum of 5000 frames were recorded with Andor Solis software at an integration 
time of 100 ms, a preamplifier gain of 1, EM-gain of 200 and in frame transfer mode. The 
excitation was performed under TIR illumination to only excite and observe molecules within 
a short distance from the glass bottom.  
2.2.4.1.4 Data analysis 
RapidSTORM software and theoretical PSF was used to reconstruct the localisation from the 
video files. 
 
 
2.2.4.2 Stimulated Emission Depletion (STED) Microscopy  
2.2.4.2.1 Ghost membrane preparation 
The ghost membrane preparations were prepared as previously described (Blisnick et al., 2000). 
Briefly, uninfected erythrocytes were incubated in 40 volumes of hypotonic solution A for 15 
min at 4°C. The lysate was centrifuged for 30 min at 15 000×g, 4°C and the ghosts were 
collected and washed extensively before resuspension in 9 volumes of hypotonic solution A at 
4°C.  
Infected red blood cells were incubated in 40 volumes of hypotonic solution B for 15 min at 
4°C. The lysate was centrifuged for 30 min at 15 000×g, 4°C and the ghosts were collected at 
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the surface of the free parasite pellet, washed extensively and finally resuspended in 9 volumes 
of hypotonic solution B and stored at 4°C.  
 
2.2.4.2.2 Sample preparation and imaging 
Samples of uninfected and MACS-purified infected erythrocytes/ghost preparations were fixed 
with 4% PFA and 0.0075% GA for 30 min then washed with PBS and incubated with 5 µm of 
SiR actin for 30 min. The samples were mounted on a coverslip and first a confocal image was 
taken with the 642 nm excitation laser. Subsequently, the 775 nm laser was used to quench the 
fluorophores outside of the focal area through STED and an image was acquired. This work 
was carried out in collaboration with Dr. Janina Hahn, AG Hell.  
 
2.2.4.3 Transmission Electron Microscopy (TEM) 
Infected erythrocytes were high-pressure frozen using Balzers HPM010 (BAL-TECH AG, 
Lichtenstein) at 2100 bar (COS, University of Heidelberg). The vitreous samples were perfused, 
with slow exchange of bound water using organic solvents (anhydrous acetone) containing 
0.1% glutaraldehyde, 0.25% uranyl acetate, and 0.01% osmium tetroxide. Substitution with 
Lowicryl HM20 resins was initiated at –90°C and the temperature was increased by 10°C/h, as 
previously described (Hillmer et al., 2012). 100 nm sections were cut at room temperature and 
examined using a Zeiss EM900 transmission electron microscope at 80kV (BioQuant EM Core 
Facility, University of Heidelberg). 
 
2.2.4.4 Scanning Electron Microscopy (SEM) 
P. falciparum-infected erythrocytes were washed in phosphate buffered saline (pH 7.2) and 
fixed in 2% glutaraldehyde and 4% paraformaldehyde for at least 30 min. Samples were spread 
onto poly-lysine coated glass cover slips and sequentially dehydrated using ethanol series and  
HMDS as a final chemical dehydration step. After mounting onto SEM pin and sputter-coating 
the sample with a 10 nm layer gold particles, samples were photographed at 5 kV using a 
Hitachi S-4500 field emission scanning electron microscope. 
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2.2.5 Adhesion Assay 
Adhesion assay of parasitized RBC to CSA bound on plastic Petri dish was carried out as 
previously described (Beeson et al., 1999; Buffet et al., 1999; Viebig et al., 2005). Briefly, 
circles of approximately 0.5 cm diameter were marked on the underside of a plastic Petri dish 
for each receptor, all in triplicates. 1mg/ml purified CSA or 1% BSA was dissolved in PBS and 
20 µl of each solution were applied to indicated spots. The receptor plates were incubated 
overnight at 4°C in a humid box. Trophozoites were purified using Magnetic Activated Cell 
Sorter (MACS) column as described by Staalsoe et al., (1999) and parasitemia after purification 
calculated. Meanwhile, the receptor spots were washed 3 times with PBS and blocking with 1% 
BSA for at least 30 minutes. After washing the spots with adhesion medium, 5*106 infected 
erythrocytes were applied to each spot and incubated for 1 h at room temperature. After gently 
washing off unbound cells, the remaining cells were fixed with 2% glutaraldehyde in PBS for 
at least 2 h. After staining for 10 minutes with 10% Giemsa and allowing the plates to dry, the 
spots were imaged using Zeiss Axiovert 200M, 10x objective. 3 areas from each spots were 
randomly selected and imaged. All results shown are averages of triplicate spots of binding 
above levels recorded for the BSA control. Statistical analysis was carried out using Sigma Plot. 
2.2.6 Flow cytometry 
The text of the following paragraph has been taken from Cyrklaff et al., (2016) and has 
originally been written by myself: 
The levels of VAR2CSA present was determined using flow cytometry, as previously described 
(Barfod et al., 2006). Briefly, samples of highly synchronised trophozoite-stage parasite 
cultures were collected and washed with PBS, supplemented with 2% fetal calf serum (FCS). 
A rabbit antiserum against baculovirus-produced recombinant domains of VAR2CSA was used 
as the primary antibody. 3ml of the sera was used to label the samples for 30 min in a final 
volume of 50 ml PBS/FCS. After several washing steps, the samples were then labelled with 
1:100 Alexa 488 goat anti-rabbit IgG (HþL) (Life Technologies) and 1:100 propidium iodide 
for 30 min in a final volume of 50ml PBS/FCS. Uninfected erythrocytes were treated 
concurrently throughout as a negative control. The fluorescence was finally determined using 
a FACScalibur (Becton Dickinson) and the CellQuest Pro Software 6.0.4 BD (Franklin Lakes). 
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2.2.7 Quantification of haemoglobin content by spectroscopy (NPPs 
activation 
Highly synchronized infected red blood cells were evaluated for hemolytic capability as an 
indirect measurement of NPPs activation over the entire intraerythrocytic life cycle. Briefly, 
samples of 1x107 iRBC were collected every 4 h, washed in PBS and then suspended in 800 μl 
of isosmotic sorbitol lysis solution for 10 min at 37°C. After 2 min centrifugation at 500 g, 700 
μl of the supernatant were collected and the absorbance at 540 nm was measured in order to 
estimate the haemoglobin concentration released from the lysed cells. Hemolysis of uninfected 
erythrocytes was assessed in parallel as negative control. Duplicates of at least two independent 
samples were carried out. 
2.2.8 Oxidative pre-treatment of erythrocytes 
Erythrocytes were incubated with the candidate oxidative agents at indicated concentration for 
1 hour RT. For treatments with H2O2 and tBOOH, an equimolar concentration of DTT was 
applied to the erythrocyte after 3 PBS washings to try and restore the oxidative balance. For 
treatments with menadione sodium bisulfate and diamide, the number of washing steps was 
increased to 5. 3-4ml of medium was added on top of the blood pellet after discarding the 
supernatant from the last wash. Store at 4°C. 
2.2.9 Hemozoin Quantification 
The text of the following paragraph has been taken from Cyrklaff et al., (2016) and has 
originally been written by myself: 
The amount of hemozoin was determined as previously described (Schwarzer et al., 1992). 
Briefly, infected erythrocytes at trophozoite and schizont stages were collected by 
centrifugation and washed twice with PBS. The pellet was then osmotically lysed by adding 50 
ml of ice-cold distilled water (dH2O) before centrifugation at 4,000 rpm at 4° C for 30 min to 
precipitate the hemozoin and the membrane ghosts. After the centrifugation, the white layer of 
RBC membrane ghosts was aspirated and the sticky black hemozoin pellet underneath washed 
twice with ice-cold dH2O. These were then dissolved in 1 ml of 0.1M NaOH and incubated at 
50 °C for 10 min. The absorbance at 400 nm was used to determine the amount of hemozoin 
present; 100 ml of each sample was added to 96-well plates and a serial dilution of 0.1M haemin 
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chloride (Sigma Aldrich) was used to plot a standard curve. The concentration of hemozoin 
present in each sample was extrapolated from said graph. 
2.2.10 RNA purification and cDNA synthesis 
Synchronized trophozoite/schizont-stage iRBC were isolated by MACS, as previously 
described (Staalsoe et al., 1999). Briefly, 50 μl of packed erythrocytes with ~50% parasitaemia 
was dissolved in 1 ml of TRIzol (Invitrogen) and RNA was prepared according to the 
manufacturer's instruction. RNA pellets were dissolved in 10 μl of RNase-free water and treated 
with DNaseI (Sigma-Aldrich) for 25 min at room temperature, followed by 10 min heat 
inactivation at 65°C. DNA-free RNA samples were used for synthesis of cDNA by reverse 
transcriptase (Superscript II, Invitrogen) and random hexamer primers as described by the 
manufacturer. cDNA synthesis was performed with assistance from Sophie Adjelley, EMBL 
Heidelberg. 
2.2.11 Quantitative real-time polymerase chain reaction (qRT-PCR) 
All q-PCR measurements were performed using the LightCycler 96 system (Roche). Reactions 
were prepared in volumes of 20μl using SYBR Green PCR master mix (Applied Biosystems) 
and a primer concentration of 1μM. The following PCR cycling conditions were used: initial 
heat activation step at 95°C for 15 min, followed by 40 cycles of 95°C for 30 s, 55°C for 30 s 
and 68°C for 40s with a final extension at 68°C for 40 s. The amplification specificity for each 
primer pair was determined by melting-curve analysis of each PCR product. 
Gene specific standard curves were generated by determining the 'amplification efficiency' 
relative to the single copy endogeneous control gene (cyclophilin), based on real-time 
measurements of 10-fold dilutions of genomic DNA. Transcript abundance was determined 
according to the ΔCt (cycle threshold) method, in which the Ct value for each specific gene was 
compared with that of the endogeneous control. Both qPCR measurement and analysis was 
performed with assistance by Sophie Adjelley, EMBL Heidelberg. Primer sequences used are 
shown in section 2.1.7 (Duffy et al., 2002; Salanti et al., 2003). 
2.2.12 Sample preparation for Mössbauer spectroscopy 
5ml aliquots of uninfected pre-treated HbAA, fetal and haemoglobionpathic erythrocytes were 
shipped from Heidelberg to Krakow with dry ice, keeping the temperature within range of 4° 
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C. Further sample processing and measurement of Mössbauer spectroscopy was carried out as 
described (Cyrklaff et al., 2016).  
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3 Project I: Visualisation of erythrocyte cytoskeletal 
proteins by super-resolution microscopy 
 
Impaired actin reorganisation in infected haemoglobinopathic erythrocytes has been implicated 
as one of the possible machanisms by which these hereditry conditions protect the host against 
life-threatening complications of severe malaria (Cyrklaff et al., 2012). Previous studies have 
utilised electron microscopy (EM), more specifically cryo-electron tomography, in visualising 
the actin reorganisation in infected erythrocytes (Cyrklaff et al., 2011). However, cryo-electron 
tomography as a technique is known to require great expertise in both image acquisition and 
data processing, with low throughput and high time investments required. Electron microscopy, 
in general, is also incompatible with live-cell imaging, as water molecules in the samples need 
to either be removed, as in classical EM, or immobilised, in the case of cryo-EM, to render the 
sample compatible with imaging under high vacumm.  
Classical confocal/light microscopy, although compatible with live cell imaging and requires 
less time and expertise, is faced with the lateral resolution limit of 200 nm and axial resolution 
limit of 500 nm, restricting it from the visualisation of small, intricate structures such as 
filamentous actin in erytrocytic membrane, which is approximately 37 nm in length (Henriques 
et al., 2011; Gokhin and Fowler, 2016). The recent development of different methods in super-
resolution microscopy, also refered to as single molecule localisation microscopy (SMLM), 
have enabled scientists to overcome the diffraction limit and gained deeper understanding of 
various cellular dynamics and protein complexes, with a lateral resolution of up to 20 nm, a 
spatial resolution of up to 50 nm and a temporal resolution of 0.5-1 s (Endesfelder et al., 2010; 
Jones et al., 2011; Sauer and Heilemann, 2017). 
 
3.1 Aim of the study 
In this project, our aim was to establish a working protocol for direct stochastic optical 
reconstruction microscopy (dSTORM) in uninfected and infected erythrocytes as a higher 
throughput method of nanoscale visualization, complementary to cryo-EM. Imaging of 
differential actin reorganization in infected haemoglobinopathic and HbAA erythrocytes would 
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be used as benchmark experiments to evaluate the applicability of dSTORM for the stated 
purpose.  
 
3.2 Alexa Fluor 647 is a suitable fluorophore for dSTORM 
visualisation 
As proof of principle, fixed HeLa cells were stained with anti-tubulin and Alexa Fluor 647 
antibodies (kindly provided by Dr. Benjamin Flottman) and imaged with the total internal 
reflection (TIRF)-dSTORM set-up as well as the traditional widefield illumination for 
comparison (Fig 3-1).    
 
 
Figure 3-1 Enhanced resolution of dSTORM imaging as compared to traditional widefield microscopy.  
(a) A widefield image of a fixed HeLa cell stained with anti β-tubulin antibody and Alexa Fluor 647 was taken 
prior to dSTORM image acquisition. (b) A dSTORM reconstruction of the same sample using RapidSTORM 
software. (c) and (d) A section of the widefield image and dSTORM reconstruction were magnified to illustrate 
the higher resolution provided by dSTORM imaging.  
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As shown in panel c and d (Fig 3-1), the dSTORM reconstruction was able to more distinctly 
resolve the tubulin filaments than traditional widefield microscopy. However, areas of over-
saturation were also present, especially at the junctions where several tubulin filaments seemed 
to cross, and if one would like to further investigate these junctions, adjustments in laser 
intensity and/or antibody concentrations would need to be considered.   
Although Alexa Fluor 647 worked well in the established system of HeLa cells, two additional 
fluorophores were tested for dSTORM imaging in the erythrocytes: Alexa Fluor 488 and Alexa 
Fluor 532. As there were several key differences between imaging tubulin in HeLa cells and 
actin and spectrin in infected and uninfected erythrocytes, we thought it prudent to test and 
select the optimal fluorophore in the target system. 
Alexa Fluor 488 was selected for its ability to exhibit blinking behaviour in PBS, circumventing 
the need for toxic blinking buffers containing mercaptoethalamine (MEA) (Dempsey et al., 
2011). However, we found that the haemoglobin autofluorescence (Khandelwal and Saxena, 
2007; Zhurova et al., 2014), even after sample perforation with streptolysin-O to release the 
haemoglobin content, as well as the low blinking rate rendered this particular fluorophore 
unsuitable for use due to low signal to noise ratio (data not shown). Alexa Fluor 532 also 
exhibited high background and low blinking rate, so much so that a reconstruction was not 
possible due to low photon count (data not shown). Alexa Flour 647 performed better than the 
previous two fluorophore, although it still exhibited signs of bleaching. However, the conditions 
were able to be marginally improved by adapting the imaging buffer to include an enzymatic 
oxygen scavenging system (Buffer II) (van de Linde et al., 2011). Although signs of bleaching 
still occurred, the photon count were sufficient for reconstructions, albeit the high background 
autofluorescence still remained (Fig 3-2a and d).    
One of key difference between the test sample of HeLa cells and our erythrocyte samples was 
the fact that HeLa cells were adherent cells. This is of a significant importance in dSTORM as 
adherent cells greatly reduce the problem of ‘drifting’ caused by movements of sample during 
the image acquisition. Several immobilisation methods were tested, including Matrigel, poly-
L-Lysine coated slides as well as varying concentrations of concanavalin-A. A sequential 
coating of 0.01% Poly-L-Lysine followed by 200µg/µl concanavalin A was selected as the final 
immobilisation protocol.  
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3.3 Differences between the cytoskeletal network of uninfected and 
infected RBCs cannot be resolve with dSTORM   
3.3.1 Spectrin  
In uninfected HbAA erythrocytes, spectrin tetramers are known to form a quasi-hexagonal 
meshwork connecting to junctional complexes containing short F-actin filaments of 
approximately 37 nm in length as well as actin-binding proteins such as tropomyosin, 
tropomodulin and protein 4.1R (Gokhin and Fowler, 2016) (Lux, 2016). This lends the 
erythrocytic membrane its characteristic flexibility and tensile strength. This network is said to 
be altered by the Plasmodium parasite upon infection (Shi et al., 2013). We began our 
experiments with spectrin rather than actin because we hypothesised that the regularity of the 
meshwork structures in uninfected erythrocytes might lend itself better to visualisation. 
Uninfected and magnetically-purified, infected trophozoite-stage HbAA erythrocytes were 
fixed with 4% PFA and 0.0075% GA for 30 min, washed with PBS and briefly perforated with 
5AU of activated streptolysin-O (SLO) in order to release some haemoglobin content and 
reduce background fluorescence. The samples were then labelled with primary mouse anti-
spectrin antibody and anti-mouse Alexa Fluor 647 secondary antibody, immobilised on pre-
coated glass-bottom ibidi µ-slides and imaged at 63x magnification with Buffer II as blinking 
buffer. A minimum of 5000 frames were taken for dSTORM reconstruction using 
RapidSTORM software.   
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Figure 3-2 Visualisation of spectrin network in uninfected and infected HbAA erythrocytes using dSTORM 
Uninfected (a-c) and infected (d-f) HbAA erythrocytes were labelled with anti-spectrin antibody and visualized 
using Alexa Fluor 647 and dSTORM imaging. The white arrow in (d) indicates the position of the parasite in the 
infected cell. Selected sections of the dSTORM reconstructions from (b) and (d) were magnified and displayed in 
(c) and (f) to allow for more direct comparison between the two samples. Images shown are representative of at 
least five different independent biological replicates. uRBC – uninfected erythrocyte; iRBC – infected erythrocyte.    
 
As shown in figure 3-2c and f, there were no distinguishable differences in the apparent spectrin 
network of uninfected and infected erythrocytes. Unlike the microtubule filaments seen in 
figure 3-1b and d, it is difficult to visualise any filamentous or mesh-like structure in this case. 
Figure 3-2a and d also showed a high degree of background fluorescence regardless of the SLO-
treatment. The parasite itself also seemed to acquire an especially intense fluorescence staining 
(Fig 3-2 d). 
3.3.2 Actin  
Although we could not visualise the hexagonal meshwork structures in uninfected samples and 
no discernible differences between spectrin network of uninfected and trophozoite-infected 
erythrocytes were detected, we continued with our attempt at actin visualisation. Since the 
filamentous actin reorganised by the parasite were reported to be, on average, 150 nm in length 
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(Cyrklaff et al., 2011), we expected that the longer length may increase the resolution, 
compared to the folded spectrin network at approximately 45 nm in length (Nans et al., 2011; 
Shi et al., 2013). The fact that the phalloidin-conjugate of Alexa Flour 647 is also commercially 
available also allowed us to expect a higher labelling efficiency, leading to a higher signal-to-
noise ratio, relative to secondary antibody labelling.  
Following the same sample preparation technique, fixed uninfected and infected HbAA 
erythrocytes were stained with phalloidin-conjugated Alexa Fluor 647 and imaged using TIRF-
dSTORM.  
Although a comparison between panels a-b and d-e from figure 3-3 suggest a more uniform, 
intense staining of F-actin around the rim of the uninfected erythrocytes, a closer look at the 
dSTORM reconstructions in panels c and f showed no visible differences between F-actin 
staining in the two samples. Unlike the images of the tubulin network in HeLa cells, the 
reconstructed images of F-actin staining in infected HbAA erythrocyte did not produce clear, 
filamentous structures. Instead, the individually localised fluorophores - seen as dots in the 
images - were spread out, making it difficult to judge whether the underlying structures could 
be arranged in any form of filaments.   
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Figure 3-3  Visualisation of actin network in uninfected and infected HbAA erythrocytes using dSTORM 
Uninfected (a-c) and infected (d-f) HbAA erythrocytes were labelled with phalloidin-Alexa 647 and imaged using 
dSTORM. The white arrow in (d) indicates the position of the parasite in the infected sample. Selected sections of 
the dSTORM reconstructions from (b) and (d) were magnified and displayed in (c) and (f) to allow for more direct 
comparison between the two samples. Images shown are representative of at least five different independent 
biological replicates. uRBC – uninfected erythrocyte; iRBC – infected erythrocyte.          
 
3.3.3 dSTORM Simulation Software (SuReSim)  
We consulted Dr. Varun Ventrankamani and Dr. Frank Herrmandörfer, both of whom were 
more experienced in dSTORM imaging, regarding our results. At the time, they were involved 
in the development of  the “SuReSim”, a software which would allow users to simulate 
dSTORM reconstructions based on ‘ground truth models’ of the structure of interest with 
variable experimental parameters such as labelling intensities, epitope densities, average 
blinking number and background signal (Venkataramani et al., 2016). Data regarding the 
length, branching angles and density of F-actin in uninfected and infected erythrocytes were 
extracted from previously publish electron microscopy experiments and used as ‘ground truth 
models’ – underlying structures of interest to be imaged by dSTORM (Fig 3-4c and d). For the 
simulated dSTORM reconstruction of F-actin in uninfected erythrocytes (Fig 3-4b), a 10% 
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labelling efficiency and an epitope density of 0.015 epitopes/nm2 for phalloidin-conjugated 
Alexa Flour 647 were assumed (Faulstich et al., 1993; Venkataramani et al., 2016). The 
outcome of the SuReSim simulation was consistent with the experimental reconstruction (Fig 
3-4a) performed by Varun and Frank, as well as those performed prior to our consultation (Fig 
3-3b and c). The SuReSim output of F-actin labelling in infected erythrocytes (Fig 3-4e) also 
showed similar images to those seen in our previous experimental reconstructions (Fig 3-3e and 
f).  
 
Figure 3-4 Simulation of likely dSTORM imaging outcomes based on ground-truth models by the software 
SuReSim.  
(a) and (b) cortical actin in uninfected erythrocytes (uRBC), visualized by dSTORM imaging and SuReSim 
simulation respectively. Adapted from Venkataramani et al., (2016) Scale bar 500 nm. (c) surface-rendered view 
of infected trophozoite stage HbAA erythrocyte, reconstructed from cryo-tomographic tilt series. Actin filaments 
seen in yellow. MC – maurer’s cleft; PM – plasma membrane; k – knob. Scale bar 100 nm. Adapted from Cyrklaff 
et al., (2012). (d) extraction of actin filament coordinates from (c) to apply as ‘ground truth model’ – a basis for 
SuReSim simulation for actin in infected erythrocytes. (e) simulated dSTORM reconstruction, assuming 10% 
labelling efficiency, 20 nm axial resolution and 30 nm lateral resolution. Scale bar 500 nm. uRBC – uninfected 
erythrocyte; iRBC – infected erythrocyte.    
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3.4 Differences between the actin network of uninfected and 
infected RBCs cannot be resolve with STED 
As both our experimental results and the SuReSim simulations showed that it was unlikely for 
dSTORM to be able to resolve the differences in actin re-arrangement between uninfected and 
infected erythrocytes, we attempted another method of super-resolution imaging – namely, 
stimulated emission depletion (STED) microscopy. SiR-Actin, a far-red fluorophore developed 
by Lukinavičius et al., (2014), was an attractive option as it would further minimize the 
autofluorescence of haemoglobin in the green spectrum. This work was carried out in 
collaboration with Dr. Janina Hahn, AG Hell, University of Heidelberg.  
3.4.1 Infected erythrocytes could not be imaged with STED 
microscopy 
Samples of uninfected and magnetically-purified infected erythrocytes were fixed with 4% PFA 
and 0.0075% GA for 30 min, washed with PBS and incubated with 5 µm of SiR actin for 30 
min. The samples were mounted on a coverslip and first a confocal image was taken with the 
642 nm excitation laser (Fig 3-5a and c). Subsequently, the 775 nm laser was used to quench 
the fluorophores outside of the focal area through STED and an image was acquired (Fig 3-5b 
and d).  
While STED images showed an improved resolution of the cortical actin in uninfected red blood 
cell relative to confocal images, infected erythrocytes entirely failed to be imaged with STED 
(Fig 3-5). The initial confocal imaging of the infected sample could be performed as expected, 
but once the STED laser reached the position where the parasite resided in the infected red 
blood cell, the cell seemed to simply burst (Fig 3-5c and d). This was observed in all repeats of 
infected trophozoite-stage erythrocyte samples from at least three independent biological 
replicates.       
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Figure 3-5 STED imaging of uninfected and infected HbAA erythrocytes.  
Uninfected (a-b) and infected (c-d) HbAA erythrocytes were fixed and stained with 5 µM SiR-Actin for 30 min. 
The sample slide was then loaded onto a Leica DMI6000B microscope and confocal image was taken with 645 
nm laser, followed by STED imaging with 775nm laser (performed by Dr. Janina Hann). White arrows in (c) point 
towards the position of the parasite in the infected sample. Images shown are representative of at least three 
independent biological replicates. uRBC – uninfected erythrocyte; iRBC – infected erythrocyte.        
 
3.4.2 STED imaging cannot resolve actin on ghost membrane 
preparations  
To circumvent the problem of “exploding” infected erythrocytes, ghost membrane preparations 
from both uninfected and infected erythrocytes were prepared using hypotonic solutions and 
protease inhibitors (Blisnick et al., 2000). These samples were then fixed, labelled and imaged 
in the same way as the previous attempt. The ghost membrane preparations from infected 
erythrocytes were able to be imaged with STED without further problems (Fig 3-6e and f).   
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Figure 3-6 STED imaging of ghost preparations from uninfected and infected HbAA erythrocytes.  
Erythrocyte membrane ghosts were prepared according to stated protocol (Blisnick et al., 2000). Ghost 
preparations from uninfected (a-c) and infected (d-f) HbAA erythrocytes were fixed and stained with 5 µM SiR-
Actin for 30 min. The sample slide was then loaded onto a Leica DMI6000B microscope and confocal image was 
taken with 645 nm laser, followed by STED imaging with 775 nm laser (performed by Dr. Janina Hann). White 
arrows in (c) point towards the position of the parasite in the infected sample. Images shown are representative of 
at least three independent biological replicates. uRBC – uninfected erythrocyte; iRBC – infected erythrocyte.        
 
Although cortical F-actin from both infected and uninfected ghost preparations were now able 
to be imaged with STED, a closer look at the resolved images in panel c and f (fig 3-5) did not 
reveal any significant differences in the arrangement of actin filaments in uninfected versus 
infected samples.  
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3.5 Discussion 
Unfortunately, both dSTORM and STED microscopy failed to visualize the differential 
arrangements of cortical F-actin in uninfected and infected HbAA erythrocytes. In the case of 
dSTORM, the experimental findings were also supported by the simulations from the software 
SuReSim (Venkataramani et al., 2016). Although the length of F-actin in uninfected 
erythrocytes is reported to be approximately 37 nm, technically within the axial resolution limit 
of super-resolution microscopy (Gokhin and Fowler, 2016), we could not visualize individual 
actin filaments. One of the possible reasons could be due to the high density of actin in the 
cortical membrane of the uninfected erythrocytes (Lux, 2016; Venkataramani et al., 2016). 
Kudryashev et al., (2010) also discussed the impact of actin length and orientation and the 
subsequent effects thereof on its detection by cryo-electron tomography. Although different in 
the imaging modality and system, the paper points to several factors effecting actin visualization 
that could also play a role in our super-resolution imaging. Cortical F-actin in erythrocytes are 
reported to lie at approximately 20° to the membrane plane and have random orientations (Picart 
and Discher, 1999; Lux, 2016). As we were using 2D TIRF-dSTORM to image the cortical 
actin, the lack of information regarding the 3D arrangement of the filaments could contribute 
to the “crowding effect” of the localized fluorophore, making it more difficult to distinguish 
individual filamentous structures in the reconstructed images.  
Increasing evidence have emerged that erythrocytic F-actin is more dynamic than previously 
believed: Gokhin et al., (2015) has reported that between 25-30% of erythrocytic F-actin are 
mobile and able to undergo both lateral movements and subunit assembly/disassembly  (Gokhin 
et al., 2015; Gokhin and Fowler, 2016). In HbAA parasitized erythrocytes, surface-rendered 
views of cryo-electron tomographic tilt series have previously shown elaborate actin networks 
of filaments between 40 – 600 nm in length, with some filaments branching at 70° and 110° 
angles (Cyrklaff et al., 2011; Cyrklaff et al., 2012; Rug et al., 2014). These dynamic processes 
and transient structures could be affected by the process of sample fixation. This could explain 
why we could not visualize the longer actin filaments in infected erythrocytes, even though the 
average length were reported to be over 170 nm (Cyrklaff et al., 2016). Several recent studies 
have tried to investigate the effect of fixatives such as paraformaldehyde (PFA) and 
glutaldehyde (GA) on actin filaments in super-resolution imaging more systematically (Whelan 
and Bell, 2015; Bachmann et al., 2016; Leyton-Puig et al., 2016). While both Bachmann et al., 
(2016) and Whelan and Bell, (2015) found GA to be more efficient at preserving thin and short 
actin filaments, Leyton-Puig et al., (2016) argued that under optimal conditions, PFA performed 
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just as well as GA in structural preservation. However, these studies were performed in adherent 
cells such as HeLa or COS-7, whose actin filaments were longer and much more visible. The 
same systematic approach should also be carried out in our erythrocyte samples – but the dense 
arrangements and much shorter filaments would most likely prove problematic for 
visualization, as we have found.  
One could argue for live-cell imaging, which would remove potential artifacts that would arise 
from fixatives currently used in the sample preparation. However, the current imaging protocols 
for dSTORM and STED microscopy need to be substantially adapted first. In the case of 
dSTORM, the imaging buffer requires oxygen scavenging, which is not conducive to keeping 
cells alive (Dempsey et al., 2011). There should also be minimal movement of the cell during 
image acquisition to prevent ‘drift’ – an artifact where a photon cannot be accurately localized 
and appears elongated due to sample movement. This is of special concern with erythrocytes as 
they are non-adherent cells and the live parasite in infected samples could cause substantial 
vibration during imaging. As for STED microscopy, the high laser intensity required would 
result in phototoxicity in live cell – one must then consider a compromise between the 
resolution, size of area of interest and speed (Cox, 2015).  
The fact that STED microscopy of infected erythrocyte was only possible with ghost membrane 
preparation is another point to consider. Although the cause of the sample disruption during 
STED image acquisition of infected erythrocytes was not experimentally determined, one 
possible explanation could be the interaction between hemozoin crystal and the 775 nm STED 
laser. Lukianova-Hleb et al., (2014) reported that nanobubbles could be generated by aiming a 
short pulse of laser at the hemozoin. The absorption of the optical energy and conversion to 
heat by the crystal causes rapid evaporation of the surrounding liquid, creating nanobubbles. 
The mechanical force generated by the collapse of these nanobubbles was sufficient to destroy 
the infected erythrocyte within nanoseconds (Hleb and Lapotko, 2014). Although a 532 nm 
laser was used in the excitation pulse, one could imagine a similar scenario occurring in our 
case. Unfortunately, no absorption spectra for hemozoin above 700 nm has been reported (Lee 
et al., 2012).  
At the time of writing, Pan et al., (2018) was able to image spectrin and actin in uninfected 
erythrocyte with 3D-STORM by letting the cells adhere to poly-lysine coated coverslip before 
fixation to create a flat surface for optimal imaging. Both the spectrin and actin images reported 
had much more regular labelling than ours, most likely due to the flattened surface of the cell. 
However, the images still fail to show filamentous structures as would be seen by the 
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reconstructions from cryo-EM (Cyrklaff et al., 2011). This is not to say that STORM is inferior 
to cryo-EM – only that the extraction of relevant information such as filament length, 
orientation or branching from pointillistic reconstructions would need much more careful 
analysis of the data and one cannot rely simply on the visual information of the images as one 
may have been accustomed to in confocal microscopy.     
Despite the advances in super-resolution microscopy, cryo-EM is still a very important tool in 
imaging transient and fragile ultrastructures. Although incompatible with live cell imaging, the 
plunge-frozen sample could give us a snapshot into a cell which has been preserved at close-
to-life state. Both techniques have their own limitations but with the emergence of super-
resolution microscopy, scientists now have more options than ever in their toolbox to help 
investigate the inner workings of cells and proteins.  
   
3.6 Outlook 
Although both dSTORM and STED microscopy failed to distinguish the differences in actin 
filaments in uninfected vs HbAA-infected erythrocytes, there are still several potential 
experiments that could be attempted.    
Gokhin et al., (2015) reported a 60% decrease in soluble G-actin after treatment of the 
erythrocyte with Jasplakinolide, a drug which enhances actin nucleation. However, the 
corresponding TIRF image of F-actin shows no visible differences when compared to non-
treated samples. The differences in cortical F-actin may become more apparent at higher 
resolution. 
Cortical actin in uninfected erythrocytes are also bound by tropomyosin, tropomodulin and 
adducin. What happen to these molecules as the parasite remodels the host actin cytoskeleton 
is as yet unknown. Super-resolution microscopy may be able to help clarify the fates of these 
proteins. 
Alternatively, there are still a lot of unanswered questions with regards to parasitic protein 
export pathway, knob assembly and adhesin clustering, to name a few. Putting aside the 
problems associated with visualisation of actin and spectrin, using super-resolution microscopy 
to localise other proteins of interest might reveal some interesting paradigm – especially now 
that we are able to first use SuReSim to determine if dSTORM experiments would yield 
meaningful outcomes or not (Venkataramani et al., 2016).      
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4 Project II: Kinetics of protein export in infected 
haemoglobinopathic erythrocytes 
 
Cytoadhesion of infected erythrocytes to the microvasculature of vital organs is one of the key 
hallmarks of severe malaria pathogenesis. Both the levels of cytoadhesion and the amount of 
surface adhesin, PfEMP1, are reduced in infected haemoglobinopathic erythrocytes, relative to 
infected HbAA erythrocytes (Fairhurst et al., 2005; Cholera et al., 2008). Cyrklaff et al., (2011) 
have previously reported that Plasmodium falciparum is able to reorganise host actin 
cytoskeleton into long filamentous structures that seemed to be involved in the trafficking and 
display of PfEMP1 on knobs. This process is also found to be impaired in haemoglobinopathic 
erythrocytes (Cyrklaff et al., 2011). Coupled with the aberrant knob structures and distribution, 
these findings indicate possible disruptions in the parasitic export pathway of infected 
haemoglobinopathic erythrocytes.  
Previous studies have mostly performed experiments with infected HbAA erythrocytes or 
infected haemoglobinopathic erythrocytes at particular stages in the intra-erythrocytic life 
cycle; for instance, most adhesion assays are performed with trophozoites or schizonts, where 
the level of surface adhesin expressions are highest (Fairhurst et al., 2005; Cholera et al., 2008). 
Madhunapantula et al., (2007) characterised the adhesion phenotype of infected HbAA 
erythrocytes to placental CSPG between 6 – 46 h post infection. However, the kinetics of 
placental adhesion phenotype during the entire intraerythrocytic cycle has never been described 
for infected haemoglobinopathic erythrocytes before.   
 
4.1 Aim of the study 
In this project, we aim to investigate the kinetics of adhesion phenotype and protein export in 
infected HbAA and haemoglobinopathic erythrocytes over the course of the 48 h intra-
erythrocytic cycle. This would help to further investigate the impact of haemoglobinopathic 
erythrocytes on the parasitic protein export system and quantitatively describe the  dynamics of 
reduced cytoadhesion in more detail. 
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4.2 Infected haemoglobinopathic erythrocytes exhibited delayed and 
reduced adherence and surface antigen presentation 
Tightly synchronized FCR3-CSA parasites, pre-selected for their CSA-adhesive phenotype, 
were cultured in erythrocytes containing either HbAA, HbAS or HbCC, henceforth referred to 
only by their haemoglobin variants, for two replication cycles before the start of the 
experiments. Purified chondroitin sulfate A (CSA) was used as a surrogate receptor for 
placental malaria. The number of infected erythrocytes used for the static adhesion assay was 
kept constant between all timepoints and haemoglobin variants. All experiments were 
performed as paired and parallel assays, with infected HbAA erythrocytes as a control.  
The number of adherent cells at each timepoint was quantified and a sigmoidal function was 
fitted to the dataset for each haemoglobin variant (Fig 4-1a). Both HbAA and HbAS first 
exhibited signs of adherence around 14 h post infection (p.i.) and reached a plateau of maximal 
adherence around 26 h p.i. However, infected HbAS showed an approximately 40% reduction 
in the final number of adherent cells/mm2 relative to infected HbAA (513±102 cells/mm2 for 
HbAS and 876±211 cells/mm2 for HbAA, respectively, p < 0.01). 
A slower increase in the kinetics of adherence was also observed in infected HbAS. Linear 
functions fitted to the slope of each dataset revealed that in infected HbAS, adherence rose at a 
rate of 20±2 cells per hour, compared to 61±4 cells per hour in infected HbAA (Fig 4-1a, p < 
0.01). Infected HbCC showed no adhesive phenotype at all.   
We then went on to investigate the temporal appearance of parasitic adhesins on the erythrocytic 
surface in both HbAA and haemoglobinopathic erythrocytes (Fig 4-1b). Samples were taken at 
specified time points and fixed with 0.05% glutaldehyde (GA). Quantification of surface 
adhesins was carried out by flow cytometry, using pooled sera from individuals living in 
malaria holoendemic regions from Burkina Faso as the primary antibody. 
Similar to the trend seen in the adhesive phenotypes, surface adhesins were detected in infected 
HbAA and HbAS from 16 h p.i. onwards, with the temporal increase of 30±4 arbitrary 
fluorescence units per hour in HbAA and 10±4 arbitrary fluorescence units per hour in HbAS 
(Fig 4-1b, p < 0.01). The final plateau value for infected HbAS was also approximately 50% 
less than those for infected HbAA erythrocytes (157±20 units and 373±52 units, respectively) 
(Fig 4-1b, p < 0.01). No surface antigen was detected for infected HbCC until 36 h p.i. and the 
maximum value detected was even lower than those in infected HbAS at 94±8 arbitrary 
fluorescence units (Fig 4-1b).    
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Figure 4-1 Kinetics of adhesion and surface antigen presentation in infected HbAA and haemoglobinopathic 
erythrocytes. 
(a) Static adhesion assay was performed on tightly synchronized FCR3-CSA parasite cultures at specified time 
points between 6-40 hrs post infection. The number of CSA-adherent cells were quantified by Giemsa staining 
and image analysis with FIJI. All experiments were performed as paired and parallel assays with infected HbAA 
samples as control. Each data point represents the mean of at least three independent biological replicates with 
blood donated from at least three different donors ± standard error of the mean. (b) Surface antigen presentation 
of each Hb variant was assessed using FACS and pooled sera from residents of malaria endemic regions in Burkina 
Faso. Samples were taken at specified time points and fixed with 0.05% GA. Further steps were carried out as 
stated in the protocol. All experiments were performed in paired and parallel assays with infected HbAA samples 
as control and each data point represents the mean of at least three independent biological replicates with blood 
donated from at least three different donors ± standard error of the mean. Figures adapted from Kilian et al., (2015)   
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4.3 Infected haemoglobinopathic erythrocytes exhibited delayed 
onset and activation of the New Permeability Pathway  
As infected HbAS showed delayed kinetics in both surface adhesin presentation and adherent 
phenotype, we wondered if this phenomenon could also be seen in other pathways unrelated to 
cytoadhesion. The New Permeability Pathway (NPP), first described in  1983 by Ginsburg et 
al., (1983), is responsible for the increase in permeability of the erythrocytic membrane to a 
wide range of solutes, including amino acids, peptides, sugars and different organic and 
inorganic ions (Kirk and Lehane, 2014). The molecular components of the NPP as well as its 
physiological functions are still currently under investigation and is a matter of some debate 
(Ginsburg and Stein, 2004; Staines et al., 2004; Thomas and Lew, 2004; Kirk and Lehane, 
2014). The NPP has been hypothesised to be involved in uptake of essential nutrients from the 
plasma, excretion of parasitic waste product and the swelling of late-stages infected 
erythrocytes due to the dissipation of the Na+/K+ gradient and the subsequent influx of water 
(Mauritz et al., 2009; Kirk and Lehane, 2014).  
In order to investigate the kinetics of NPP development in parasitized HbAA and 
haemoglobinopathic erythrocytes, sorbitol-induced haemolysis was used as a read-out. Samples 
of highly synchronised parasites were taken every 4 h throughout the 48 h intra-erythrocytic 
cycle and lysed in iso-osmotic sorbitol lysis buffer as previously described (Kirk et al., 1994). 
Spectroscopic absorbance at 540 nm wavelength (A540) is correlated to the amount of 
haemoglobin released due to cell lysis. This was used to semi-quantitatively describe the 
establishment and functionality of the NPP as the osmosis of water into the cell would increase 
after influx of sorbitol through the NPP, driving cell lysis. All experiments were performed in 
a paired and parallel assay with infected HbAA erythrocytes as control. The mean of at least 
three independent experiments ± standard error of mean for each timepoint and each 
haemoglobin variant was plotted, and a three parameter Hill function fitted to each dataset (Fig 
4-2). For ease of visual comparison, a dotted line indicating 50% induction of the NPP in 
infected HbAA erythrocyte was also shown. This corresponded to 26 h p.i. in infected HbAA 
and 30 h p.i. in both infected HbAS and HbAC erythrocytes (Fig 4-2). F-statistic also showed 
a significant difference between the timecourses of NPP induction and development between 
infected HbAA and HbAS and HbAA and HbAC (Fig 4-2, p < 0.001 in both cases) but no 
significant difference between infected HbAS and HbAC samples (Fig 4-2, p < 0.77).     
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Figure 4-2 Induction of the new permeability pathways (NPP) in infected HbAA and haemoglobinopathic 
erythrocytes.  
Samples of infected erythrocytes were taken at specified timepoints throughout the 48 h intra-erythrocytic cycle.  
Onset and development of the NPP were assessed through sorbital-induced hemolysis. Absorption spectroscopy 
at 540 nm wavelength (A540) was used to quantify the amount of haemoglobin released. Dotted line designates a 
50% NPP induction in infected HbAA erythrocytes. All experiments were performed in paired and parallel assays 
with infected HbAA samples as control and each data point represents the mean of at least three independent 
biological replicates with blood donated from at least three different donors ± standard error of the mean. Statistical 
significance between each dataset was calculated using F-statistics (p < 0.001 between HbAA and HbAS, p < 
0.001 between HbAA and HbAC and p < 0.77 between HbAS and HbAC). a.u. – arbitrary units. Figure adapted 
from Waldecker et al., (2017). Data generated in a collaboration with Dr. Christine Lansche.  
 
4.4 Discussion 
Our timecourse for CSA-adhesion in infected HbAA erythrocytes agreed well with previously 
publish result for adherence to Cluster of Differentiation 36 (CD36), intercellular adhesion 
molecule-1 (ICAM-1) and thrombospondin (TSP) (Gardner et al., 1996). In contrast, 
Madhunapantula et al., (2007) showed that adhesion to isolated placental chondroitin sulfate 
proteoglycan (CSPG) exhibits a peak adhesion at 22 to 26 h p.i. then the binding capacity 
gradually decreased during trophozoite maturation instead of remaining constant. They have 
argued that this could be due to the increase in apperance of other parasitic export proteins on 
the surface of the infected erythrocytes, which could sterically mask the chondroitin-4-sulfate 
(C4S) binding protein(s). They hypothesised that the parasite could utilize this mechanism to 
limit exposure of the adhesin to the host immune system. However, this seems somewhat self-
contradictory since the reduction in binding capability at the late trophozoite/schizont stage 
 Project II: Kinetics of protein export 
 
63 
would also result in many parasitized erythrocytes being unable to escape splenic clearance and 
thus enable the host to generate of parasite-specific adaptive immune response, to the detriment 
of the remaining parasites (Engwerda et al., 2005; Del Portillo et al., 2012).  
One possible explaination for the discrepancy between our result and those published by 
Madhunapantula et al., (2007) could be the difference in the ligand used for the adhesion assays: 
bovine chondroitin sulfate A (CSA) was used in our experiment while low-sulfated CSPG 
isolated from the placenta was used in theirs. Although many studies have previously used 
CSA-coated petri dishes to investigate the binding characteristics of CSA-adherent iRBCs 
(Beeson et al., 1999; Achur et al., 2000; Alkhalil et al., 2000), new methodologies have 
emerged which attempt to mimic in vivo settings more closely. Placental cryosections have 
previously been used (Flick et al., 2001; Avril et al., 2004; Muthusamy et al., 2004) but one 
could argue that the fixation and cryopreservation may cause some damage to the receptors and 
epitopes present, despite attempts otherwise. The fixation and cryopreservation also prevented 
studies of signalling pathways and downstream consequnces of the binding on the trophoblasts 
(Lucchi et al., 2006). For such studies, as well as further cytoadhesion studies, the human 
syncytiotrophoblast and the choriocarcinoma cell line (BeWo) has been adopted (Haase et al., 
2006; Lucchi et al., 2006; Viebig et al., 2006). Most recently, Pehrson et al., (2016) described 
a method to profuse freshly donated placenta for ex vivo studies of adherent phenotypes under 
physiological flow conditions in the villous trees. Although this is by far the method with 
conditions nearest to the in vivo placental tissue, it does require access to the labor ward and 
prompt delievery of freshly donated placenta, so it remains to be seen if this method could 
become more widely used in the field.       
With regards to the adherence phenotype of infected haemoglobinopathic erythrocytes (Fig 4-
1a), our results are in good agreement with previously published data, even though the receptors 
under investigation were different: infected HbCC erythrocytes show no adhesion to both 
human dermal microvascular endothelial cells (HDMECs) and human microvascular 
endothelial cells (HMVECs) (Fairhurst et al., 2005; Cholera et al., 2008) and infected HbAS 
show approximately 50% reduction in adhesion to HMVECs relative to infected HbAA 
erythrocytes (Cholera et al., 2008).  
The detection of surface antigen at 16 h p.i. (Fig 4-1b) is also supported by both Kriek et al., 
(2003) and Dahlbäck et al., (2007) for parasitized HbAA erythrocytes. The timing is consistant 
with the results published by Kyes et al., (2000), demonstrating that transcription of var genes 
begins as early as 3 h p.i. and peaks at approximately 10-12 h p.i. Cholera et al., (2008) showed 
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that the reduction in surface PfEMP1 signal for parasitised HbAS erythrocytes is approximately 
14% relative to parasitized HbAA, which is much lower than our 50% reduction. However, this 
maybe explained by the fact that pooled sera was used in our experiments while PfEMP1-
specific antibody was used in the other study. For parasitized HbCC erythrocytes, our result of 
approximately 75% reduction in surface antigen presentation relative to parasitized HbAA 
erythrocytes is also in agreement with previously published data (Fairhurst et al., 2005).  
The delayed onset of the NPPs seen in infected haemoglobinopathic erythrocytes are also in 
agreement with other reports of delayed protein export in infected haemoglobinopathic 
erythrocytes (Kilian et al., 2015). No significant reduction in the replication rates and hemozoin 
digestion in infected haemoglobinopathic erythrocytes were observed in our experiments 
(Waldecker et al., 2017), also in agreement with previously published report (Kilian et al., 
2015). NPP impacts the volumetric changes of the infected erythrocyte over the course of the 
intra-erythrocytic life cycle through the pertubation of the Na+/K+ gradient. The delay in its 
establishment would account for the delay in volume expansion seen in infected HbAC 
erythrocytes as well as infected HbAS, although to a lesser extent (Waldecker et al., 2017). Not 
only does the change in cell shape affects its cytoadhesive properties such as contact area as 
well as its behaviour in flow, it also affects endothelial cell activation and host immune 
responses (Lansche et al., manuscript under preparation). This would most likely contribute to 
the molecular mechanism by which haemoglobinopathic erythrocytes protect its carrier against 
the severe complications of malaria.  
 
4.5 Outlook 
Our results contribute to the growing collection of evidence that delayed protein export, reduced 
surface adhesin presentation and reduced cytoadhesive phenotype are involved in the protection 
of haemoglobinopathic carriers against severe malaria. However, more molecular detail behind 
this protection remains to be elucidated.  
Previous reports suggest that the parasite’s inability to reorganise host actin cytoskeleton in 
infected haemoglobinopathic erythrocytes leads to the impaired presentation of PfEMP1 
adhesin at the erythrocytic surface as actin is believed to be involved in vesicular transport of 
proteins between the Maurer’s clefts and the knobs (Cyrklaff et al., 2011; Cyrklaff et al., 2012; 
Rug et al., 2014). Our result with the delayed establishment of NPP in infected 
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haemoglobinopathic erythrocyte suggests a wider range of affected proteins and processes. It 
would be interesting to investigate the fates of proteins involved in both the export pathway 
between the parasitophorous vacuole (PVM) and the erythrocyte cytoplasm such as components 
of the PTEX (Chisholm Scott et al., 2018). In addition, the involvement of chaperones and other 
proteins in transporting the parasitic protein through the host cytoplasm to the Maurer’s clefts 
such as PfTRiC (Mbengue et al., 2015) remains to be investigated for infected 
haemoglobinopathic erythrocytes.     
Kilian et al., (2013) also reported that in infected haemoglobinopathic erythrocytes, the 
movements of the Maurer’s clefts were faster compared to infected HbAA erythrocytes. 
Additionally, the malformed Maurer’s cleft ultrastructures seen in electron micrographs of 
infected haemoglobinopathic erythrocytes (Cyrklaff et al., 2011; Cyrklaff et al., 2016) strongly 
suggest that both the formation and the function of the Maurer’s clefts have been adversely 
affected. Insights into the protein sorting machinery and the establishment and maintenance of 
the Maurer’s clefts, as well as the fates of its resident proteins, would also be of great benefit to 
our understanding of the molecular mechanism of protection against severe malaria conferred 
by haemoglobinopathic erythrocytes.   
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5 Project III: Oxidative pre-treatment of uninfected 
erythrocytes to mimic the protective phenotypes of 
haemoglobinopathic erythrocytes  
As previously mentioned, there have been many reports describing the differences between 
infected HbAA and haemoglobinopathic erythrocytes in cytoadhesion, protein transport 
kinetics, host actin remodelling as well as knobs and Maurer’s clefts morphologies (Fairhurst 
et al., 2005; Cholera et al., 2008; Cyrklaff et al., 2011; Cyrklaff et al., 2012; Kilian et al., 2013; 
Kilian et al., 2015; Waldecker et al., 2017). Fetal haemoglobin (HbF) is also believed to be one 
of the key contributing factors to the protection against severe malaria in the first six months of 
life, with reported impaired cytoadhesion and abnormal display of PfEMP1 on the erythrocytic 
surface (Amaratunga et al., 2011). Although the precise molecular mechanisms underlying 
these changes have yet to be elucidated, some features appear to be common to the 
haemoglobinopathies conferring protective phenotypes. These include abnormal accumulation 
of heme and hemichromes on the erythrocytic membranes as well as an abundance of reactive 
oxygen species (ROS) such as superoxide radicals generated from accelerated heme 
autooxidation (Hebbel et al., 1982; Hebbel et al., 1988; Chaves et al., 2008). Oxidised forms 
of haemoglobin also interfere with the parasite’s ability to remodel host actin into long 
filamentous network (Cyrklaff et al., 2011). However, the involvement of oxidative stress and 
oxidised haemoglobin products as parts of the mechanisms of protection against severe malaria 
by haemoglobinopathic erythrocytes has yet to be investigated.    
5.1 Aim of the study 
In order to examine the involvement of oxidative stress and irreversibly oxidised haemoglobin 
as a mechanism of protection against severe malaria, the pro-oxidative environment of 
uninfected haemoglobinopathic erythrocytes will be experimentally replicated. 
Uninfected HbAA erythrocytes were transiently exposed to various oxidative agents prior to 
infection with Plasmodium falciparum parasites. Various parameters associated with 
pathogenicity such as cytoadhesion, levels of surface PfEMP1, and knobs and Maurer’s cleft 
morphologies were investigated to determine the degree to which the oxidative pre-treatments 
were able to replicate the effects seen in infected haemoglobinopathic or fetal erythrocytes.    
 Project III: Oxidative pre-treatment of uninfected erythrocytes 
 
67 
5.2 Transient oxidative insult to uninfected HbAA erythrocytes 
reduces cytoadhesion and surface VAR2CSA expression, 
phenotypes characteristic of infected haemoglobinopathic and 
fetal erythrocytes  
Uninfected HbAA erythrocytes were subjected to transient oxidative stress through incubation 
with 1 mM of either hydrogen peroxide (H2O2), tert-butyl hydroperoxide (tBOOH) or 
menadione sodium bisulfite (MD). Both H2O2 and tBOOH have been widely used as oxidising 
agents in various in vitro systems (Srivastava et al., 1974; Caprari et al., 1995; Zou et al., 2001) 
and are able to diffuse freely across the plasma membrane due to their small size and lipophilic 
nature, respectively. Menadione sodium bisulfite, also used as a water-soluble form of vitamin 
K3 precursor in animal feeds, has likewise been widely used to study oxidative stress (Chiou 
and Tzeng, 2000; Criddle et al., 2006; Heart et al., 2012). It generates intracellular ROS through 
redox-cycling in the presence of molecular oxygen (Thor et al., 1982; Desagher et al., 1997; 
Criddle et al., 2006). This would more closely reflect the physiological conditions found in 
haemoglobinopathic erythrocytes, where ROS are constantly generated, in contrast to direct 
exposure to H2O2, which has a more transient effect (Heart et al., 2012). 
The irreversibly oxidised ferryl haemoglobin and hemichromes have been shown to inhibit in 
vitro actin polymerisation and destabilise interactions between actin, spectrin and protein 4.1 
(Jarolim et al., 1990; Cyrklaff et al., 2011). Reversible oxidative damage caused by the transient 
oxidative pre-treatment was alleviated by incubating the freshly pre-treated erythrocytes with 1 
mM dithiothreitol (DTT) (Caprari et al., 1995) before storage and use in cell culture of 
Plasmodium falciparum. We also treated uninfected HbAA erythrocytes with DTT alone to 
control for possible effects that may arise from the reducing agent. The treatment of HbCC with 
DTT would serve as a control to distinguish between possible effects of reversible and 
irreversible oxidative damage on the aberrant morphologies and cytoadhesive phenotypes seen 
in infected HbCC erythrocytes.  
The fitness of the parasites grown in pre-treated, haemoglobinopathic or fetal erythrocytes were 
monitored through replication rates and hemozoin quantification. The replication rates of 
parasites grown in all Hb variants and pre-treated HbAA were recorded over at least eight 
replication cycles and the mean ± SEM is summarised in Table 5-1. As indicated, both the 
parasitized pre-treated erythrocytes and those cultivated in haemoglobinopathic or fetal 
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erythrocytes have comparable replication rates to infected HbAA erythrocytes, similar to 
previous reports (Kilian et al., 2013; Kilian et al., 2015).  
While the replication rates demonstrated that the parasites were able to complete their asexual 
replication cycle regardless of the haemoglobin variant or the pre-treatments of HbAA 
erythrocytes that they have been cultured in, the comparable amount of hemozoin incorporation 
suggests that the parasites cultured in all conditions were equally metabolically active during 
their intra-erythrocytic life cycle (table 5-1).   
 
Table 5-1 Replication rate and hemozoin digestion levels of parasites in haemoglobinopathic and pre-treated 
HbAA erythrocytes.  
FCR3-CSA parasites were cultured in indicated haemoglobin variant or pre-treated HbAA erythrocytes and the 
replication rates documented over at least eight replication cycles. The mean replication rates ± standard error of 
mean is displayed below. The amount of hemozoin digested by schizont-stage parasite cultivated in designated 
haemoglobin variant or pre-treated HbAA erythrocytes for at least two replication cycles was quantified according 
to stated protocol (Schwarzer et al., 1992). All experiments were done as paired and parallel assays with infected 
HbAA as positive control. The value is the mean of at least three independent biological replicates ± standard error 
of mean. H2O2 – hydrogen peroxide; tBOOH – tert-butyl peroxide; MD – menadione; DTT – dithiothreitol.   
 
Hb variant Replication Rate 
(per cycle) 
Normalised amount of 
hemozoin (%) 
HbAA 11.5 ± 0.7 100 
HbAS 10.8 ± 0.5 108 ± 5 
HbAC 12.1 ± 0.4 98 ± 19 
HbF 11.8 ± 0.4 106 ± 4 
HbAA – H2O2 11.7 ± 0.5 104 ± 2 
HbAA – tBOOH 10.9 ± 0.6 107 ± 4 
HbAA – MD 11.1 ± 0.3 113 ± 13 
HbAC – DTT 10.6 ± 0.5 97 ± 8 
HbAA – DTT 12.1 ± 0.4 106 ± 3 
 
After at least two replication cycles in specified Hb variant or pre-treated HbAA, tightly 
synchronised trophozoite stage parasitized erythrocytes were taken as samples to investigate 
their CSA-adhesion phenotype and the amount of surface-presented VAR2CSA (Fig 5-1a and 
b). To measure the CSA-adhesive phenotype, 1 mg/ml of purified bovine CSA were used as a 
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surrogate receptor for parasite adhesion in placental intervillous space. The amount of adhesive 
parasites were stained with Giemsa and quantified microscopically. All experiments were 
performed in paired and parallel assays and normalised to their respective infected HbAA 
control sample (Fig 5-1a). Each dot on the graph represents an independent experiment and the 
mean for each Hb variant is indicated by the red line.  
Relative to infected HbAA control, all infected haemoglobinopathic, fetal or pre-treated Hb AA 
erythrocytes exhibited significantly reduced CSA adhesion (P < 0.001 according to Kruskal-
Wallis one-way analysis of variance test). The level of CSA adhesion seen in pre-treated HbAA 
erythrocytes was also of comparable range to those seen in parasitized haemoglobinopathic and 
fetal erythrocytes: iHbAS 53%, iHbAC 27%, iHbF 45%, iHbAA-H2O2 25%, iHbAA-tBOOH 
33%, iHbAA-MD 16% (Fig 5-1a). Pre-treatment of uninfected HbAA with DTT alone had no 
effect on the adhesion phenotype (Fig 5-1a, iHbAA-DTT) while pre-treatment of HbAC with 
DTT could not rescue the reduced adherence phenotype (Fig 5-1a, iHbAC-DTT). 
A similar trend was observed for the amount of surface VAR2CSA detected by flow cytometry 
(Fig 5-1b). The amount of VAR2CSA detected on the erythrocytic surface was significantly 
reduced in infected fetal and haemoglobinopathic erythrocytes as well as in infected pre-treated 
HbAA erythrocytes, relative to infected HbAA erythrocytes (P < 0.001 according to Kruskal-
Wallis one-way analysis of variance test). Pre-treatment of HbAC with DTT still resulted in the 
same level of VAR2CSA as those seen in infected HbAC erythrocytes.  
To investigate the cause of the reduction in cytoadherence and surface adhesin presentation in 
more detail, the mRNA expression level of var2csa was quantified with quantitative reverse 
transcription PCR (qRT-PCR). Instead of collecting the samples at trophozoite stage as we’ve 
done for the previous two assays, the samples were collected at ring stage, approximately 12 h 
p.i., as it was shown to be the peak of var transcription level (Kyes et al., 2000; Dahlbäck et al., 
2007). The mRNA level of cyclophilin was used as internal control and the result for each 
condition was normalised to the paired infected HbAA control sample. The mean of at least 
three independent biological replicates and three independent blood donors ± SEM for each 
condition was plotted (Fig 5-1c). There were no statically significant differences between the 
var2csa mRNA levels of all infected Hb variants and pre-treatments.     
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Figure 5-1 Effects of oxidative pre-treatments of HbAA erythrocytes on CSA adhesion, surface PfEMP1 
levels and mRNA expression level, relative to infected haemoglobinopathic and fetal erythrocytes. 
Prior to infection with the CSA adhesive strain of Plasmodium falciparum (FCR3-CSA), uninfected HbAA 
erythrocytes were transiently exposed to 1 mM of different oxidative agents; either hydrogen peroxide (H2O2), 
tert-butyl peroxide (tBOOH) or menadione (MD). 1 mM of dithiothreitol (DTT) was used to restore the redox 
balance of the uninfected HbAA erythrocytes after the oxidative pre-treatment. The prefix “i” indicates infected 
erythrocytes. All experiments were performed in paired and parallel assays with infected HbAA erythrocytes as 
control. (a) After at least two replication cycles in pre-treated, haemoglobinopathic or fetal erythrocytes, the level 
of CSA-adhesiveness at trophozoite stage (20 – 30 h p.i.) was measured. Each dot in the graph represents a mean 
value for an independent experiment, normalised to its paired HbAA values. The red line indicates the mean values 
for each Hb variant or pre-treatments. *P < 0.001 compared with parasitized HbAA erythrocytes (Kruskal-Wallis 
one-way analysis of variance test). (b) Amount of surface VAR2CSA presented was detected by flow cytometry 
with rabbit antiserum against recombinant domains of VAR2CSA. Samples were harvested at trophozoite stage 
(24-26 h p.i.) and prepared according to previously published protocol (Barfod et al., 2006). The mean fluorescence 
was normalised to infected HbAA readouts in each paired experiment. Error bars indicate SEM. *P < 0.001 
compared with parasitized HbAA erythrocytes (Kruskal-Wallis one-way analysis of variance test). (c) var2csa 
mRNA levels in parasitized Hb variants and pre-treated HbAA erythrocytes as detected by qRT-PCR. Samples 
were harvested at ring stages (12 h p.i.) and prepared according to established protocol (Cyrklaff et al., 2016). The 
qPCR results were normalised against levels of cyclophilin transcripts in each sample as internal controls. The 
result for each conditions was normalised to its paired HbAA value and the mean plotted. Error bars indicate SEM. 
Figure adapted from Cyrklaff et al., (2016). 
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5.3 Infected pre-treated HbAA erythrocytes exhibited knob and 
Maurer’s cleft morphologies comparable to infected 
haemoglobinopathic erythrocytes  
 
The morphologies of the Maurer’s clefts and knobs in infected haemoglobinopathic and fetal 
erythrocytes have previously been reported by Cholera et al., (2008), Fairhurst et al., (2005) 
and Amaratunga et al., (2011). However, the TEM sample preparations were done through 
chemical fixation and Epon embedding. In order to minimize possible artifacts and 
ultrastructural damages, we perserved our samples with high pressure freezing/freeze 
substitution (HFP/FS) for TEM examinations. As opposed to chemical fixation, where the rate 
at which the sample can be preserved is limited by the diffusion of fixatives or cross linkers 
through the sample, HPF repidly freezes the sample at very low temperatures in a nanoseconds 
timescale. This allows preservation of the ultrastructures as well as other processes in the cell, 
whereby the water inside and around the cell turns to vitreous ice and prevents formation of ice 
crystals that would damage the structures (Griffiths et al., 1984; Müller and Moor, 1984; 
Griffiths et al., 1993).  
In order to avoid possible artifacts and discrepancies that may arise due to differences in sample 
preparation techniques, we chose to prepare all samples by HPF instead of relying on previously 
published images for the knobs and Maurer’s cleft morphologies. Transmission electron 
micrograph of 100 nm thick sections are shown in figure 5-2, first column (TEM). Magnified 
images of knobs and Maurer’s clefts can be seen to the right of the images. We did not detect 
any distinguishable morphological differences in the developing parasites grown in 
haemoglobinopathic, fetal or oxidatively pre-treated erythrocytes (Fig 5-2). However, both 
oxidatively pre-treated samples and DTT-treated HbAC sample exhibited ulterations in their 
ultrastructures such as enlarged and dispersed knobs as well as malformed Maurer’s clefts. The 
aberrant knob distribution and phenotypes could be more clearly observed in scanning electron 
micrograph (Fig 5-2, right column); only infected HbAA erythrocytes exhibited small, regular, 
and numerous knobs on the surface of the infected erythrocyte.  
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Figure 5-2 Ultrastructural morphologies in infected Hb variants and pre-treated HbAA erythrocytes.  
Parasitized trophozoite-stage erythrocytes cultured for at least two replication cycles in haemoglobinopathic, fetal 
or pre-treated HbAA erythrocytes were taken for imaging with transmission and scanning electron microscopy 
(TEM and SEM, respectively) to examine the knob and Maurer’s clefts morphologies. Samples for TEM were 
prepared by high-pressure freezing and freeze-substitution, as previously described (McDonald, 2007). A 
representative from at least 25 images was selected for display in each condition. A zoomed in section of knobs 
and Maurer’s clefts are shown in the inset. SEM samples were prepared according to previously published protocol 
(Cyrklaff et al., 2016). After chemical dehydration through ethanol series and hexamethyldisalzan, samples were 
sputter-coated with 5 nm gold and imaged with SEM. Images displayed are representative of at least 25 images in 
each condition. Scale bar 2 µm. H2O2 - hydrogen peroxide; MD – menadione; DTT – dithiothreitol. Figure adapted 
from Cyrklaff et al., (2016). 
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5.4 Pre-treatment of uninfected HbAA erythrocytes elevated the 
levels of irreversibly oxidized haemoglobin to those comparable 
with haemoglobinopathic and fetal erythrocytes 
The pre-treatment of uninfected HbAC with the reducing agent DTT prior to infection was 
unable to rescue the aberrant knobs and Maurer’s cleft morphologies as well as the reduced 
adhesion phenotype. This strongly suggests the involvement of irreversible oxidized 
haemoglobin species in the molecular mechanisms behind the observe phenomena. In order to 
more precisely quantify the levels of irreversibly oxidized hemoglobin in differently treated 
erythrocytes, Mössbauer spectroscopy was used. This was performed in collaboration with the 
group of Kvestoslava Burda in Krakow, where we shipped our samples of the uninfected 
haemoglobinopathic, fetal or oxidatively pre-treated erythrocytes. The samples were from three 
independent pre-treatments or donors and were all examined by Mössbauer spectroscopy within 
one week of pre-treatment or acquisition, to avoid the confounding effects of erythrocyte aging. 
The mean values of oxy-haemoglobin, met-haemoglobin and irreversibly oxidised 
haemoglobin species found in each haemoglobin variant/ pre-treatment are summarised in 
Table 5-2.  
Table 5-2 Levels of oxidized haemoglobin species found in different variants of uninfected erythrocytes.  
Mössbauer spectroscopy was used to measure the levels of various species of oxidized haemoglobin in uninfected 
haemoglobinopathic and pre-treated HbAA erythrocytes. The results are an average between at least three different 
independent biological replicates ± standard error of mean. H2O2 – hydrogen peroxide; tBOOH – tert-butyl 
peroxide; MD – menadione; Hb – haemoglobin; Oxy-Hb – oxy-haemoglobin; Met-Hb – met-haemoglobin. Table 
adapted from Cyrklaff et al., (2016).  
Hb variant Oxy-Hb (%) Met-Hb (%) Irreversibly oxidized Hb (%) 
HbAA 94.0 1.0 5.0 
HbAS 85.6 2.3 12.2 
HbAC 83.5 3.9 12.6 
HbF 84.7 3.1 12.2 
HbAA – H2O2 78.1 1.3 20.6 
HbAA – tBOOH 77.7 5.4 16.9 
HbAA – MD 70.1 7.3 22.0 
 
In all haemoglobinopathic, fetal or pre-treated samples, the levels of irreversibly oxidised 
haemoglobin were markedly higher than those seen in uninfected HbAA. Interestingly, the level 
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of met haemoglobin in the H2O2 pre-treated sample was comparable to those seen in uninfected 
HbAA erythrocytes. Pre-treatment with menadione, on the other hand, seems to elevate the 
level of met-haemoglobin even higher than those found in haemoglobinopathic erythrocytes.    
5.5 Discussion 
Haemoglobinopathic erythrocytes such as HbS and HbC are known to have reduced lifespan in 
circulation as well as higher accumulation of hydroxyl radicals due to haemoglobin instability 
and auto-oxidation (Hebbel et al., 1982; Hebbel et al., 1988; Rees et al., 2010; Hannemann et 
al., 2011). Previous reports have shown that parasitized HbS, HbC and HbF exhibit reduced 
cytoadhesion, reduced surface PfEMP1 levels and enlarged and dispersed knobs (Fairhurst et 
al., 2005; Cholera et al., 2008; Amaratunga et al., 2011). Here, we were able to implicate 
irreversibly oxidized haemoglobin species as possible causative agents of the aforementioned 
protective phenotypes through the pre-treatment of HbAA erythrocytes with oxidative agents. 
The comparable replication rates and hemozoin digestion levels between parasitized pre-treated 
HbAA erythrocytes and untreated HbAA control showed that the parasites had no problems 
growing in the pre-treated HbAA erythrocytes. This was also the case for infected 
haemoglobinopathic and fetal erythrocytes, both in our experiment and previously published 
studies (Fairhurst et al., 2005; Cholera et al., 2008; Amaratunga et al., 2011). Moreover, the 
aberrant knobs sizes and distribution, as well as the malformed Maurer’s clefts previously seen 
in infected haemoglobinopathic and fetal erythrocytes were also observed in our pre-treated 
samples, along with comparable reduction in cytoadhesion and surface adhesin levels.  
The fact that pre-treatment of uninfected HbAC erythrocytes with a reducing agent (DTT) could 
not restore the cytoadhesion, surface adhesin levels and Maurer’s cleft and knob morphologies 
to those seen in infected HbAA erythrocytes points to the involvement of irreversibly oxidized 
molecules in these processes. Surface rendered views of cryo-electron tomographic tilt series 
also showed that parasites in pre-treated HbAA erythrocytes were unable to reorganize host 
actin into long filamentous network, similar to those seen in infected haemoglobinopathic and 
fetal erythrocytes (Cyrklaff et al., 2016). Although all of the oxidative agents used in our study 
have been shown to interact with actin in various ways (Bellomo et al., 1990; Caprari et al., 
1995; DalleDonne et al., 1995; DalleDonne et al., 1999), this would not have been the cause of 
the aberrant host actin remodelling seen in the infected pre-treated erythrocytes as the H2O2 , 
tBOOH and menadione were only transiently applied to the uninfected erythrocytes and were 
subsequently removed through washing steps and incubation with equimolar concentration of 
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DTT. What could be of interest, however, are the molecular mechanisms through which these 
oxidising agents exert their effects. H2O2 is able to rapidly generate ferryl (Fe
4+) haemoglobin 
and can form the highly reactive hydroxyl radical (OH·) through the ferrous iron-dependent 
reaction (Fenton, 1894; van den Berg et al., 1992). tBOOH is found to rapidly generate radicals 
after reacting with cellular haemoglobin and also readily oxidized glutathione (Van der Zee et 
al., 1989; Caprari et al., 1995; Rossi et al., 2001; Domanski et al., 2005). Menadione is reported 
to undergo redox-cycling in the presence of molecular oxygen, thereby generating intracellular 
ROS, including H2O2 (Thor et al., 1982; Desagher et al., 1997; Criddle et al., 2006; Loor et al., 
2010). It is also reported to oxidise the haem groups of oxy-hemoglobin to met-hemoglobin 
and, to a smaller extent, hemichrome (Winterbourn et al., 1979). This would explain the highly 
elevated level of met-haemoglobin found in the MD-treated sample, according to our 
Mössbauer spectroscopy results (Table 5-2).    
As previous studies have suggested that actin is involved in proper formation and establishment 
of Maurer’s clefts, vesicular trafficking of parasitic proteins to the erythrocytic surface and 
knob formation, it is tempting to attribute the functional outcome of reduced surface adhesin 
presentation and cytoadhesion to disruption in the protein export pathway due to interference 
of irreversible oxidized haemoglobin products and other ROS with actin (Rug et al., 2006; 
Kilian et al., 2013; Cyrklaff et al., 2016). However, both the delayed establishment of NPPs 
seen in our experiment and a previously published paper by Kilian et al., (2015) suggest a 
broader effect of the oxidative stress in haemoglobinopathic erythrocytes on the parasitic 
processes and transport system, not just actin. The delayed and reduced amounts of protein 
translocation across the parasitophorous vacuole in infected haemoglobinopathic erythrocytes, 
relative to infected HbAA erythrocytes, begs the question of which other components may have 
been adversely affected by the oxidative milieu found in haemoglobinopathic erythrocytes. 
Although the results from the pre-treated infected erythrocytes seem promising, confirmation 
with ex vivo field isolates would also be ideal as long-term parasite cultures have been shown 
to lower the adherence as well as knob densities of the lab strains, compared to field isolates 
(Achur et al., 2008; Quadt et al., 2012). The fact that alterations to the knob morphologies and 
reduced cytoadhesion observed in haemoglobinopathic erythrocytes infected with lab-strains 
and ex vivo field isolates were reported to be comparable suggests that our findings could also 
be representative of field isolates (Fairhurst et al., 2005; Cholera et al., 2008).    
As pre-treatment with menadione was able to mimic the phenotypes seen in infected 
haemoglobinopathic and fetal erythrocytes and menadione as a drug is approved for use in 
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human, Cyrklaff et al., (2016) further extended this research to the malaria mouse model with 
Plasmodium berghei and C57BL/6 mice. Although the mice model system remains 
controversial in many aspects, including an altered pathogenesis of cerebral malaria compared 
to those found in humans and the lack of PfEMP1 orthologues (Cabrales et al., 2010; White et 
al., 2010; Craig et al., 2012), the fact that the mice pre-treated with intraperitoneal injection of 
menadione before challenge with Plasmodium berghei ANKA infected erythrocytes develop 
significantly less brain damage, microhaemorrhage and blood-brain barrier disruption than the 
untreated control remains promising. After all, one of the proposed mechanisms of action of 
artesunate, the current drug of choice for treatment of severe malaria, is through increased 
intracellular ROS and subsequent DNA damage to the parasite (Gopalakrishnan and Kumar, 
2015; WHO, 2015a).   
Taken together, our results suggest a key role for inherent oxidative stress and irreversibly 
oxidised haemoglobin as a starting point in a cascade of events, including delayed protein 
export and aberrant actin remodelling, which eventually lead to reduced cytoadhesion of 
haemoglobinopathic erythrocytes, protecting its carrier from severe complications of malaria. 
However, the overall picture is still far from complete. Previously published studies suggest a 
more complex, multifactorial mechanisms of protection against severe malaria, including 
disruption of parasitic protein translation by host microRNAs (LaMonte et al., 2012), increased 
phagocytosis of infected HbAS erythrocyte by monocytes (Ayi et al., 2004; Lang et al., 2009) 
and host immune modulation (Ferreira et al., 2011). There is also emerging evidence suggesting 
that infected haemoglobinopathic erythrocytes have reduced endothelial cell activation upon 
binding (Lansche et al., manuscript in preparation), adding another piece to the complex puzzle 
that is the molecular mechanisms underlying the protection against severe malaria by 
haemoglobinopathic erythrocytes.   
5.6 Outlook 
Further characterisation of the parasitized pre-treated HbAA erythrocytes would be of great 
interest, especially to investigate how far the induced similarities between the parasitized pre-
treated erythrocytes and the haemoglobinopathic erythrocytes runs. For example, whether the 
parasitized pre-treated HbAA erythrocytes are able to induce endothelial cell activation or 
whether parasitic protein transport would also be delayed at the parasitophorous vacuole (Kilian 
et al., 2015).    
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Along the same line, it would also be interesting to investigate how individual components of 
the Plasmodium translocon of exported proteins (PTEX) are affected in both 
haemoglobinopathic and pre-treated erythrocytes (Przyborski et al., 2016). Other proteins of 
interest might include PfTRiC as well as human TRiC, where conflicting reports claimed either 
one or the other is involved in chaperoning parasitic proteins through the host cytoplasm to the 
Maurer’s cleft (Mbengue et al., 2015; Batinovic et al., 2017). This may help to narrow down 
which section(s) of the parasitic protein export pathway are particularly adversely affected. 
Glucose-6-phosphate dehydrogenase (G6PD) is a key enzyme involved in the erythrocyte’s 
antioxidant response, as it catalyses the reduction of nicotinamide adenine dinucleotide 
phosphate (NADP+) into NADPH (Peters and Van Noorden, 2009). G6PD-deficiency is 
widespread in Africa, Asia, the Middle East and the Mediterranean, with allele frequencies of 
up to 30%, giving rise to the hypothesis that this is due to the selective pressure exerted by the 
malaria parasite (Ruwende and Hill, 1998; Uyoga et al., 2015). However, the epidemiological 
evidence for the protection of G6PD-deficiency against malaria is found to be confusing and 
often contradictory (Mbanefo et al., 2017). As we have pointed to pro-oxidative environments 
and irreversibly oxidised haemoglobin products as one of the key factors in the protective roles 
of haemoglobinopathic erythrocytes against severe malaria, further investigation into G6PD-
deficient erythrocytes could prove insightful. 
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6 Conclusion 
Despite many epidemiological studies linking haemoglobinopathies to protection against severe 
malaria, the molecular mechanisms behind the protective traits have yet to be elucidated. 
In project I, we attempted to establish a working protocol for visualisation of actin and spectrin 
in uninfected and infected erythrocytes using 2D TIRF-dSTORM. Unfortunately, we were not 
able to distinguish between the short F-actin in uninfected erythrocytes and long filamentous 
actin remodelled by the parasite upon infection. STED imaging also yielded similar results. 
Kinetics of cytoadhesive phenotype, surface adhesin presentation and induction and 
establishment of the new permeation pathways (NPPs) were investigated in project II. Infected 
haemoglobinopathic erythrocytes showed delayed and reduced levels of cytoadhesion, surface 
adhesin presentation and NPPs development, compared to infected HbAA erythrocytes. These 
results suggest an impaired parasitic protein export pathway in parasitized haemoglobinopathic 
erythrocytes. 
In order to determine the effects of irreversibly oxidised haemoglobin products and elevated 
levels of reactive oxygen species (ROS) inherent in uninfected haemoglobinopathic 
erythrocytes on the parasite’s ability to remodel the host cell, uninfected HbAA erythrocytes 
were transiently oxidised prior to infection by Plasmodium falciparum in project III. The pre-
treated samples exhibited reduced cytoadhesion and surface PfEMP1 levels, comparable to 
infected haemoglobinopathic and fetal erythrocytes. Maurer’s clefts and knob morphologies, as 
investigated by transmission and scanning electron microscopy, were also visually similar to 
those seen in infected fetal and haemoglobinopathic erythrocytes, namely enlarged and 
dispersed knobs as well as malformed Maurer’s clefts. 
Based on the studies described above, we hypothesise that one of the molecular mechanisms by 
which haemoglobinopathic and fetal erythrocytes protect their carriers against severe malaria 
is due to their inherent oxidative imbalance as well as elevated levels of reactive oxygen species 
(ROS) and irreversibly oxidised haemoglobin products such as ferryl-haemoglobin and 
hemichromes. These interfere with the parasite’s ability to establish functional Maurer’s clefts, 
knobs and long filamentous actin networks in the host cytoplasm, resulting in reduced export 
of  PfEMP1 to the erythrocytic surface, reduced cytoadhesion and, consequently, a reduced risk 
of severe malaria for their carriers (Fig 6-1).  
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Figure 6-1  Current model for one of the molecular mechanisms of protection against severe malaria by 
haemoglobinopathic and fetal erythrocytes. 
Top panel: Under normal circumstances, HbA-containing erythrocytes are able to mitigate and reverse possible 
damages from haemoglobin oxidation associated reactive oxygen species (ROS), including globin-based radicals 
(Hb·). Once infected with Plasmodium falciparum, the parasite carries out several changes in its host cell, 
including: establishing parasitic membranous structures termed Maurer’s clefts in the erythrocytic cytosol, 
displaying parasitic adhesins on membrane protrusions termed knobs and reorganising host actin into long 
filamentous structures connecting the Maurer’s clefts and the knobs. These modifications allow the parasitized 
erythrocyte to cytoadhere in microvascular beds of vital organs and causes severe complications in malaria which 
could lead to coma and death. Bottom panel: In haemoglobinopathic and fetal erythrocytes, the elevated levels of 
oxidative stress and ROS interfere with the Maurer’s clefts and knobs morphologies as well as the host actin 
remodelling, leading to reduced cytoadhesion and less likelihood of developing severe malaria for their carriers. 
Transient oxidative treatment of HbAA erythrocytes is able to replicate the morphologies and phenotypical 
outcomes of infected haemoglobinopathic or fetal erythrocytes. Figure adapted from Cyrklaff et al., (2016) 
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